Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transmembrane transporter activity	ABCA12 PKD1L1 SLCO3A1 PKDREJ RYR2 CLCN5 CLCNKB SLC9B2 PKD1 SLC37A2 SLC49A3 SLC35E4 SLC23A2 CACNB2 PKD2L1 GRIA3 SLC6A15 GRIA4 SLC22A12 SLC25A22 SLC7A3 SLC12A4 SLC2A6 SLC25A1 GSDMD SLC15A5 SV2C SLC7A5 SLC25A47 SLC12A7 NALF2 ATP2B3 SLC16A8	5.83e-06	1180	241	33	GO:0022857
GeneOntologyMolecularFunction	transporter activity	ABCA12 PKD1L1 SLCO3A1 PKDREJ RYR2 CLCN5 CLCNKB SLC9B2 PKD1 SLC37A2 SLC49A3 SLC35E4 SLC23A2 CACNB2 RHBDF2 PKD2L1 GRIA3 SLC6A15 GRIA4 SLC22A12 SLC25A22 SLC7A3 SLC12A4 SLC2A6 SLC25A1 GSDMD SLC15A5 SV2C SLC7A5 SLC25A47 SLC12A7 NALF2 ATP2B3 SLC16A8	1.43e-05	1289	241	34	GO:0005215
GeneOntologyMolecularFunction	secondary active transmembrane transporter activity	SLCO3A1 CLCN5 SLC9B2 SLC37A2 SLC35E4 SLC23A2 SLC6A15 SLC25A22 SLC12A4 SLC25A1 SLC15A5 SLC7A5 SLC12A7 SLC16A8	1.57e-05	296	241	14	GO:0015291
GeneOntologyMolecularFunction	organic anion transmembrane transporter activity	SLCO3A1 SLC37A2 SLC23A2 GRIA3 SLC6A15 GRIA4 SLC25A22 SLC7A3 SLC2A6 SLC25A1 SLC7A5 SLC25A47 SLC16A8	6.08e-05	293	241	13	GO:0008514
GeneOntologyMolecularFunction	calcium ion transmembrane transporter activity	PKD1L1 PKDREJ RYR2 PKD1 CACNB2 PKD2L1 GRIA3 NALF2 ATP2B3	9.34e-05	151	241	9	GO:0015085
GeneOntologyMolecularFunction	calcium channel activity	PKD1L1 PKDREJ RYR2 PKD1 CACNB2 PKD2L1 GRIA3 NALF2	1.74e-04	129	241	8	GO:0005262
GeneOntologyMolecularFunction	active transmembrane transporter activity	ABCA12 SLCO3A1 CLCN5 SLC9B2 SLC37A2 SLC35E4 SLC23A2 SLC6A15 SLC25A22 SLC12A4 SLC25A1 SLC15A5 SLC7A5 SLC12A7 ATP2B3 SLC16A8	2.38e-04	477	241	16	GO:0022804
GeneOntologyMolecularFunction	semaphorin receptor activity	PLXNB2 MET PLXNA2	3.52e-04	12	241	3	GO:0017154
GeneOntologyMolecularFunction	5-methylcytosine dioxygenase activity	TET2 TET1	4.32e-04	3	241	2	GO:0070579
GeneOntologyMolecularFunction	all-trans retinoic acid 18-hydroxylase activity	CYP26A1 CYP26B1	4.32e-04	3	241	2	GO:0062183
GeneOntologyCellularComponent	myosin filament	MYH1 MYH4 MYH13 OBSCN	1.86e-04	25	243	4	GO:0032982
GeneOntologyCellularComponent	extracellular matrix	LRRC3C MATN4 PLXNB2 COCH SPON2 ADAMTS15 PLAT DMBT1 PLXNA2 HSPG2 COL8A2 VWF LAMA2 LAMA4 BCAN TGM2 LTBP3 LGR6 HCFC1	2.56e-04	656	243	19	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	LRRC3C MATN4 PLXNB2 COCH SPON2 ADAMTS15 PLAT DMBT1 PLXNA2 HSPG2 COL8A2 VWF LAMA2 LAMA4 BCAN TGM2 LTBP3 LGR6 HCFC1	2.66e-04	658	243	19	GO:0030312
GeneOntologyCellularComponent	A band	MYH1 HDAC4 OBSCN RYR2 ANK2	3.39e-04	52	243	5	GO:0031672
GeneOntologyCellularComponent	collagen-containing extracellular matrix	MATN4 PLXNB2 COCH ADAMTS15 PLAT DMBT1 PLXNA2 HSPG2 COL8A2 VWF LAMA2 LAMA4 BCAN TGM2 LTBP3 HCFC1	5.04e-04	530	243	16	GO:0062023
Domain	EGF_Lam	STAB1 ATRN HSPG2 LAMA2 LAMA4 MEGF8 MEGF10	2.77e-07	35	242	7	SM00180
Domain	Laminin_EGF	STAB1 ATRN HSPG2 LAMA2 LAMA4 MEGF8 MEGF10	2.77e-07	35	242	7	PF00053
Domain	Laminin_EGF	STAB1 ATRN HSPG2 LAMA2 LAMA4 MEGF8 MEGF10	5.04e-07	38	242	7	IPR002049
Domain	EGF_LAM_2	STAB1 ATRN HSPG2 LAMA2 LAMA4 MEGF8	2.04e-06	30	242	6	PS50027
Domain	EGF_LAM_1	STAB1 ATRN HSPG2 LAMA2 LAMA4 MEGF8	2.04e-06	30	242	6	PS01248
Domain	PKD_channel	PKD1L1 PKDREJ PKD1 PKD2L1	8.45e-06	11	242	4	PF08016
Domain	PKD1_2_channel	PKD1L1 PKDREJ PKD1 PKD2L1	8.45e-06	11	242	4	IPR013122
Domain	REJ	PKD1L1 PKDREJ PKD1	8.51e-06	4	242	3	PS51111
Domain	REJ_dom	PKD1L1 PKDREJ PKD1	8.51e-06	4	242	3	IPR014010
Domain	EGF	MATN4 STAB1 UMOD PLAT ATRN HSPG2 LAMA2 LAMA4 BCAN MEGF8 SLIT1 LTBP3 MEGF10	1.26e-05	235	242	13	SM00181
Domain	EGF-like_dom	MATN4 STAB1 UMOD PLAT ATRN HSPG2 LAMA2 LAMA4 BCAN MEGF8 SLIT1 LTBP3 MEGF10	2.33e-05	249	242	13	IPR000742
Domain	EGF_1	MATN4 STAB1 UMOD PLAT ATRN HSPG2 LAMA2 LAMA4 BCAN MEGF8 SLIT1 LTBP3 MEGF10	2.99e-05	255	242	13	PS00022
Domain	-	IFT172 EML2 PLXNB2 MET PLXNA2 DCAF4L2 DYNC2I2 CORO2A DYNC2I1 CORO1A SCAP PRPF4 WDR6 NUP133 MAPKBP1	3.13e-05	333	242	15	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	IFT172 EML2 PLXNB2 MET PLXNA2 DCAF4L2 DYNC2I2 CORO2A DYNC2I1 CORO1A SCAP PRPF4 WDR6 NUP133 MAPKBP1	3.35e-05	335	242	15	IPR015943
Domain	EGF-like_CS	MATN4 STAB1 UMOD PLAT ATRN HSPG2 LAMA2 LAMA4 BCAN MEGF8 SLIT1 LTBP3 MEGF10	3.81e-05	261	242	13	IPR013032
Domain	PKD/REJ-like	PKD1L1 PKDREJ PKD1	4.18e-05	6	242	3	IPR002859
Domain	REJ	PKD1L1 PKDREJ PKD1	4.18e-05	6	242	3	PF02010
Domain	Plexin_repeat	PLXNB2 MET PLXNA2 ATRN MEGF8	5.30e-05	32	242	5	IPR002165
Domain	PSI	PLXNB2 MET PLXNA2 ATRN MEGF8	5.30e-05	32	242	5	PF01437
Domain	-	LDLRAD2 KREMEN1 CSMD3 DMBT1 ATRN MEGF8	5.50e-05	52	242	6	2.60.120.290
Domain	CUB_dom	LDLRAD2 KREMEN1 CSMD3 DMBT1 ATRN MEGF8	9.29e-05	57	242	6	IPR000859
Domain	Gal_Oxase/kelch_b-propeller	KLHL9 ATRN KLHDC9 MEGF8 WDR6 HCFC1	1.13e-04	59	242	6	IPR011043
Domain	Tet_JBP	TET2 TET1	1.67e-04	2	242	2	PF12851
Domain	Ribosomal_S27e	RPS27 RPS27L	1.67e-04	2	242	2	IPR000592
Domain	2OGFeDO_noxygenase_dom	TET2 TET1	1.67e-04	2	242	2	IPR024779
Domain	Ribosomal_S27e_Zn-bd_dom	RPS27 RPS27L	1.67e-04	2	242	2	IPR023407
Domain	Rhomboid_SP	RHBDF1 RHBDF2	1.67e-04	2	242	2	PF12595
Domain	Ribosomal_S27e	RPS27 RPS27L	1.67e-04	2	242	2	PD004466
Domain	RIBOSOMAL_S27E	RPS27 RPS27L	1.67e-04	2	242	2	PS01168
Domain	Rhomboid_SP	RHBDF1 RHBDF2	1.67e-04	2	242	2	IPR022241
Domain	Ribosomal_S27e	RPS27 RPS27L	1.67e-04	2	242	2	PF01667
Domain	-	RPS27 RPS27L	1.67e-04	2	242	2	2.20.25.100
Domain	Tet_JBP	TET2 TET1	1.67e-04	2	242	2	SM01333
Domain	AA-permease/SLC12A_dom	SLC7A3 SLC12A4 SLC7A5 SLC12A7	1.67e-04	22	242	4	IPR004841
Domain	AA_permease	SLC7A3 SLC12A4 SLC7A5 SLC12A7	1.67e-04	22	242	4	PF00324
Domain	EGF_2	MATN4 STAB1 UMOD PLAT ATRN HSPG2 LAMA2 BCAN MEGF8 SLIT1 LTBP3 MEGF10	1.85e-04	265	242	12	PS01186
Domain	EGF	MATN4 STAB1 UMOD PLAT ATRN HSPG2 BCAN SLIT1	2.39e-04	126	242	8	PF00008
Domain	PSI	PLXNB2 MET PLXNA2 ATRN MEGF8	2.52e-04	44	242	5	IPR016201
Domain	EGF_3	MATN4 STAB1 UMOD PLAT ATRN HSPG2 BCAN MEGF8 SLIT1 LTBP3 MEGF10	2.58e-04	235	242	11	PS50026
Domain	PSI	PLXNB2 MET PLXNA2 ATRN MEGF8	3.11e-04	46	242	5	SM00423
Domain	MFS_dom	SLCO3A1 SLC37A2 SLC49A3 SLC22A12 SLC2A6 SLC15A5 SV2C SLC16A8	3.63e-04	134	242	8	IPR020846
Domain	IPT	PLXNB2 MET NFATC4 PLXNA2	3.82e-04	27	242	4	SM00429
Domain	Ig_E-set	MYCBP2 PLXNB2 MET NFATC4 PLXNA2 TGM2 EPB42	4.11e-04	104	242	7	IPR014756
Domain	CUB	KREMEN1 CSMD3 DMBT1 ATRN MEGF8	4.20e-04	49	242	5	PF00431
Domain	EGF_dom	STAB1 UMOD MEGF8	4.34e-04	12	242	3	IPR024731
Domain	EGF_3	STAB1 UMOD MEGF8	4.34e-04	12	242	3	PF12947
Domain	CUB	KREMEN1 CSMD3 DMBT1 ATRN MEGF8	4.62e-04	50	242	5	SM00042
Domain	WD40	IFT172 EML2 DCAF4L2 DYNC2I2 CORO2A DYNC2I1 CORO1A SCAP PRPF4 WDR6 MAPKBP1	5.86e-04	259	242	11	PF00400
Domain	CUB	KREMEN1 CSMD3 DMBT1 ATRN MEGF8	6.06e-04	53	242	5	PS01180
Domain	TIG	PLXNB2 MET NFATC4 PLXNA2	6.57e-04	31	242	4	PF01833
Domain	IPT	PLXNB2 MET NFATC4 PLXNA2	7.43e-04	32	242	4	IPR002909
Domain	WD40	IFT172 EML2 DCAF4L2 DYNC2I2 CORO2A DYNC2I1 CORO1A SCAP PRPF4 WDR6 MAPKBP1	7.77e-04	268	242	11	SM00320
Domain	Myosin_N	MYH1 MYH4 MYH13	8.71e-04	15	242	3	PF02736
Domain	Myosin_N	MYH1 MYH4 MYH13	8.71e-04	15	242	3	IPR004009
Domain	WD40_repeat	IFT172 EML2 DCAF4L2 DYNC2I2 CORO2A DYNC2I1 CORO1A SCAP PRPF4 WDR6 MAPKBP1	8.77e-04	272	242	11	IPR001680
Domain	Glyco_hydro_31_CS	SI GAA	9.86e-04	4	242	2	IPR030459
Domain	Gal_mutarotase_N	SI GAA	9.86e-04	4	242	2	IPR031727
Domain	PC1	PKD1 PKD2L1	9.86e-04	4	242	2	IPR000434
Domain	NtCtMGAM_N	SI GAA	9.86e-04	4	242	2	PF16863
Domain	KCL_cotranspt	SLC12A4 SLC12A7	9.86e-04	4	242	2	IPR000076
Domain	Growth_fac_rcpt_	MATN4 STAB1 UMOD ATRN HSPG2 MEGF8 SLIT1 LTBP3	9.90e-04	156	242	8	IPR009030
Domain	WD_REPEATS_1	IFT172 EML2 DCAF4L2 DYNC2I2 CORO2A DYNC2I1 CORO1A SCAP PRPF4 WDR6 MAPKBP1	1.05e-03	278	242	11	PS00678
Domain	EGF_CA	MATN4 STAB1 UMOD HSPG2 MEGF8 SLIT1 LTBP3	1.07e-03	122	242	7	SM00179
Domain	WD_REPEATS_2	IFT172 EML2 DCAF4L2 DYNC2I2 CORO2A DYNC2I1 CORO1A SCAP PRPF4 WDR6 MAPKBP1	1.08e-03	279	242	11	PS50082
Domain	WD_REPEATS_REGION	IFT172 EML2 DCAF4L2 DYNC2I2 CORO2A DYNC2I1 CORO1A SCAP PRPF4 WDR6 MAPKBP1	1.08e-03	279	242	11	PS50294
Domain	EGF-like_Ca-bd_dom	MATN4 STAB1 UMOD HSPG2 MEGF8 SLIT1 LTBP3	1.17e-03	124	242	7	IPR001881
Domain	GPS	PKD1L1 PKDREJ PKD1 ADGRL1	1.30e-03	37	242	4	IPR000203
Domain	LAM_G_DOMAIN	HSPG2 LAMA2 LAMA4 SLIT1	1.44e-03	38	242	4	PS50025
Domain	LH2	PKD1L1 PKDREJ PKD1	1.52e-03	18	242	3	SM00308
Domain	Myosin_tail_1	MYH1 MYH4 MYH13	1.52e-03	18	242	3	PF01576
Domain	Myosin_tail	MYH1 MYH4 MYH13	1.52e-03	18	242	3	IPR002928
Domain	WSC	KREMEN1 PKD1	1.63e-03	5	242	2	SM00321
Domain	GLYCOSYL_HYDROL_F31_2	SI GAA	1.63e-03	5	242	2	PS00707
Domain	Laminin_domII	LAMA2 LAMA4	1.63e-03	5	242	2	IPR010307
Domain	WSC	KREMEN1 PKD1	1.63e-03	5	242	2	PS51212
Domain	WSC_carb-bd	KREMEN1 PKD1	1.63e-03	5	242	2	IPR002889
Domain	WSC	KREMEN1 PKD1	1.63e-03	5	242	2	PF01822
Domain	Laminin_aI	LAMA2 LAMA4	1.63e-03	5	242	2	IPR009254
Domain	Laminin_I	LAMA2 LAMA4	1.63e-03	5	242	2	PF06008
Domain	Laminin_II	LAMA2 LAMA4	1.63e-03	5	242	2	PF06009
Domain	PKD_2	PKDREJ PKD2L1	1.63e-03	5	242	2	IPR003915
Domain	DMAP_binding	DIP2A DNMT1	1.63e-03	5	242	2	PF06464
Domain	Laminin_G_2	HSPG2 LAMA2 LAMA4 SLIT1	1.74e-03	40	242	4	PF02210
Domain	WD40_repeat_dom	IFT172 EML2 DCAF4L2 DYNC2I2 CORO2A DYNC2I1 CORO1A SCAP PRPF4 WDR6 MAPKBP1	1.77e-03	297	242	11	IPR017986
Domain	Myosin-like_IQ_dom	MYH1 MYH4 MYH13	1.79e-03	19	242	3	IPR027401
Domain	-	MYH1 MYH4 MYH13	1.79e-03	19	242	3	4.10.270.10
Domain	Ig-like_fold	MYLK MYCBP2 UNC5B OBSCN PLXNB2 MET PTPRH NFATC4 NEGR1 MPZL3 IL1R2 PLXNA2 HSPG2 BCAN TGM2 CD22 GPCPD1 HCFC1 EPB42	2.19e-03	706	242	19	IPR013783
Domain	-	PKD1L1 PKDREJ PKD1	2.40e-03	21	242	3	2.60.60.20
Domain	PLAT	PKD1L1 PKDREJ PKD1	2.40e-03	21	242	3	PF01477
Domain	PLAT/LH2_dom	PKD1L1 PKDREJ PKD1	2.40e-03	21	242	3	IPR001024
Domain	PLAT	PKD1L1 PKDREJ PKD1	2.40e-03	21	242	3	PS50095
Domain	DMAP1-bd	DIP2A DNMT1	2.42e-03	6	242	2	IPR010506
Domain	Glyco_hydro_31_AS	SI GAA	2.42e-03	6	242	2	IPR030458
Domain	DMAP_binding	DIP2A DNMT1	2.42e-03	6	242	2	SM01137
Domain	LamG	HSPG2 LAMA2 LAMA4 SLIT1	2.49e-03	44	242	4	SM00282
Domain	-	MYLK MYCBP2 UNC5B OBSCN PLXNB2 MET NFATC4 NEGR1 MPZL3 IL1R2 PLXNA2 HSPG2 BCAN TGM2 CD22 GPCPD1 HCFC1 EPB42	2.60e-03	663	242	18	2.60.40.10
Domain	-	MATN4 COCH SEC23A VWF CPNE5	2.73e-03	74	242	5	3.40.50.410
Domain	MFS	SLC37A2 SLC49A3 SLC22A12 SLC2A6 SV2C SLC16A8	2.83e-03	108	242	6	PS50850
Domain	MFS_1	SLC37A2 SLC49A3 SLC22A12 SV2C SLC16A8	3.25e-03	77	242	5	PF07690
Domain	MFS	SLC37A2 SLC49A3 SLC22A12 SV2C SLC16A8	3.25e-03	77	242	5	IPR011701
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TBC1D9B MYCBP2 MFHAS1 OBSCN EML2 PLXNB2 ZDHHC8 ADCY7 ESRP2 DIP2A LMAN2L PSME4 PKD1 NLGN2 METTL27 ARHGAP21 MED12 TBCD DOCK3 HSPG2 RHBDF1 RHBDF2 ZNF316 ZDHHC5 ADGRL1 C8orf58 FAM83H DHX30 SLC25A22 SCAP IGF2R SLC12A4 MEGF8 SLC7A5 LTBP3 MAPKBP1 HCFC1 SMAD7	1.33e-15	1105	250	38	35748872
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	MYCBP2 LEMD3 CD55 PLXNB2 MET COCH LMAN2L NEGR1 SGPL1 MTCH2 ARHGAP21 PCSK9 DNMT1 ATRN HSPG2 FAM234B NAT14 LAMA4 APEX1 SLC6A15 GRN STT3B TGM2 SCAP IGF2R GTF3C1 MEGF8 SLC7A5 LTBP3 MSLN	3.61e-09	1201	250	30	35696571
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	LEMD3 UNC5B ZDHHC8 MET ARHGAP21 PLXNA2 ITCH RHBDF1 ANK2 RHBDF2 KIF16B ZDHHC5 SLC6A15 PARP14 STT3B IGF2R SLC12A4 SLC7A5 SLC12A7	3.86e-08	569	250	19	30639242
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	LEMD3 UNC5B PLXNB2 MET ARHGAP21 CACNB2 ITCH RALGAPB ZDHHC5 ADGRL1 SLC6A15 IGF2R WDR6 SLC7A5 PLCH1 SLC12A7	8.29e-08	421	250	16	36976175
Pubmed	Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.	PLXNB2 HNRNPF MET COCH MTCH2 ATRN HSPG2 APMAP GRN STT3B SLC25A22 TGM2 IGF2R MEGF8 SLC25A1 NUP133 AGK LTBP3 GAA	1.23e-07	613	250	19	22268729
Pubmed	Protein interactome reveals converging molecular pathways among autism disorders.	TBC1D9B MYCBP2 STAB1 NGRN DNMT1 VWF ADGRL1 GRN CORO1A MEGF8 SLIT1 SPRYD3 NUP133 HAGH GRIP2 LTBP3 MAPKBP1 MEGF10	1.56e-07	560	250	18	21653829
Pubmed	Different roles for Tet1 and Tet2 proteins in reprogramming-mediated erasure of imprints induced by EGC fusion.	TET2 DNMT1 TET1	3.67e-07	3	250	3	23453809
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	MYH1 MYH4 OBSCN HNRNPF ESRP2 DIP2A POP1 PKD1 ADAMTS15 ATRN CDC42BPG CYP26B1 TMEM14A ZNF316 PCARE GRN PARP14 GTF3C1 RPE65 MEGF10	4.58e-07	736	250	20	29676528
Pubmed	Two members of the TRPP family of ion channels, Pkd1l3 and Pkd2l1, are co-expressed in a subset of taste receptor cells.	PKD1L1 PKDREJ PKD1 PKD2L1	5.29e-07	10	250	4	16805797
Pubmed	Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins.	RPS27 PLXNB2 SGPL1 MTCH2 ATRN NAT14 ITCH APMAP USH1C STT3B RPS27L SLC25A22 IGF2R SLC12A4 AGK SLC7A5	8.02e-07	499	250	16	22810586
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	PLCXD1 PLXNB2 CKB PSMG2 LMAN2L CLCN5 SGPL1 SLC23A2 ARHGAP21 TBCD NAT14 ZDHHC5 STT3B FAM83H IGF2R SLC12A4 WDR6 SLC7A5 SLC12A7	1.35e-06	719	250	19	35337019
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	MYCBP2 ME2 HNRNPF CKB POP1 NOP2 MED12 SEC23A DNMT1 NUP107 PHRF1 ZCCHC3 DHX30 IGF2R GTF3C1 WDR6 NUP133 HCFC1	1.43e-06	653	250	18	22586326
Pubmed	Tet proteins connect the O-linked N-acetylglucosamine transferase Ogt to chromatin in embryonic stem cells.	TET2 TET1 HCFC1	1.46e-06	4	250	3	23352454
Pubmed	Comparative sequence analysis of the complete human sarcomeric myosin heavy chain family: implications for functional diversity.	MYH1 MYH4 MYH13	1.46e-06	4	250	3	10388558
Pubmed	[DNA hypomethylation in villi of patients with unexplained recurrent spontaneous abortion and its mechanism].	TET2 DNMT1 TET1	1.46e-06	4	250	3	31167695
Pubmed	UVB induces cutaneous squamous cell carcinoma progression by de novo ID4 methylation via methylation regulating enzymes.	TET2 DNMT1 TET1	1.46e-06	4	250	3	32574963
Pubmed	Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle.	MYH1 MYH4 MYLK	1.46e-06	4	250	3	11029314
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	IFT172 DGKB CSMD3 NEGR1 SLC23A2 ARHGAP21 PLXNA2 RALGAPB ADGRL1 DHX30 MEGF8 SLIT1 GPCPD1 MAPKBP1	1.76e-06	407	250	14	12693553
Pubmed	ER-export and ARFRP1/AP-1-dependent delivery of SARS-CoV-2 Envelope to lysosomes controls late stages of viral replication.	LEMD3 UNC5B RPS27 LMAN2L SGPL1 SEC23A KIF16B ZDHHC5 SLC6A15 APRT STT3B RPS27L DHX30 SCAP IGF2R SLC12A4 WDR6 SLC25A1 NUP133 AGK SLC7A5 SLC12A7	1.78e-06	952	250	22	38569033
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	MYCBP2 RPS27 TYSND1 PLXNB2 LANCL2 HNRNPH3 CKB MET LMAN2L POP1 MTCH2 DNMT1 ATRN ITCH APEX1 APRT STT3B DHX30 TBC1D13 SLC25A22 IGF2R WDR6 HACL1 HAGH HCFC1 GAA	2.74e-06	1297	250	26	33545068
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	DGKB FN3K NEGR1 SGPL1 NLGN2 ARHGAP21 DYNC2I2 CORO2A DYNC2I1 ADGRL1 GRIA3 GRIA4 TGM2 AGK	3.32e-06	430	250	14	32581705
Pubmed	Polycystin channels and kidney disease.	PKDREJ PKD1 PKD2L1	3.63e-06	5	250	3	11698076
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	MATN4 PLXNB2 DMBT1 HSPG2 VWF LAMA2 LAMA4 TGM2 HCFC1	3.70e-06	167	250	9	22159717
Pubmed	Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.	LEMD3 PLXNB2 ZDHHC8 DIP2A SLC23A2 RHBDF1 WWP2 ZDHHC5 SLC6A15 SLC12A4 CD22 SLC7A5 ATP2B3	4.02e-06	377	250	13	38117590
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	RPS27 LANCL2 HNRNPF HNRNPH3 SGPL1 POP1 NOP2 DNMT1 ITCH CORO2A KRT84 ZCCHC3 STT3B FAM83H DHX30 SLC25A22 TGM2 GTF3C1 PRPF4 WDR6 SLC25A1 NUP133 AGK SLC7A5 IMP3	4.94e-06	1257	250	25	36526897
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	TBC1D9B LEMD3 PLXNB2 PLAT METTL16 MTCH2 SEC23A TBCD DNMT1 FAM234B NAT14 ITCH NUP107 SLC6A15 STT3B SLC25A22 SCAP IGF2R SLC25A1 NUP133 GAA	5.35e-06	942	250	21	31073040
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	PLXNB2 DMBT1 PLXNA2 HSPG2 VWF LAMA2 LAMA4 TGM2 HCFC1	5.42e-06	175	250	9	28071719
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	HNRNPF DIP2A PSME4 SGPL1 POP1 METTL16 ARHGAP21 DNMT1 CDC42BPG RALGAPB TMEM177 TGM2 GTF3C1 WDR6 PLCH1 SLC12A7 HCFC1	5.64e-06	650	250	17	38777146
Pubmed	Functional proteomics mapping of a human signaling pathway.	MYCBP2 LEMD3 RYR2 PKD1 TBCD HSPG2 VWF WWP2 LAMA4 GRN DHX30 TGM2 SLC12A4 LTBP3 SMAD6 SMAD7	6.96e-06	591	250	16	15231748
Pubmed	Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved.	MYH1 MYH4 MYH13	7.22e-06	6	250	3	10077619
Pubmed	SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB.	GPHN ME2 HNRNPH3 MTCH2 SEC23A TBCD CKMT1A NUP107 IDH3A APRT STT3B DHX30 CORO1A SLC25A1 NUP133 AGK	9.69e-06	607	250	16	39147351
Pubmed	A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease.	UNC5B TYSND1 HNRNPF HNRNPH3 SGPL1 DMBT1 MSS51 ARHGAP21 CACNB2 NRAP PKD2L1 TET1 SLIT1	1.12e-05	415	250	13	16385451
Pubmed	A fast Myosin super enhancer dictates muscle fiber phenotype through competitive interactions with Myosin genes.	MYH1 MYH4 MYH13	1.26e-05	7	250	3	35210422
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	RPS27 ME2 LANCL2 HNRNPF HNRNPH3 CKB NOP2 MTCH2 SEC23A DNMT1 CKMT1A NUP107 APMAP IDH3A STT3B DHX30 SLC25A22 IGF2R GTF3C1 PRPF4 WDR6 NUP133 AGK SLC7A5 ATP2B3 HCFC1	1.44e-05	1425	250	26	30948266
Pubmed	USP15 targets ALK3/BMPR1A for deubiquitylation to enhance bone morphogenetic protein signalling.	ITCH WWP2 SMAD6 SMAD7	1.72e-05	22	250	4	24850914
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	TBC1D9B PLXNB2 SGPL1 ITCH DYNC2I2 WWP2 KIF16B DHX30 GTF3C1 WDR6 HCFC1	1.88e-05	313	250	11	38270169
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	GPHN LEMD3 SGPL1 SEC23A ITCH KIF16B SLC6A15 STT3B SCAP IGF2R SLC12A4 MEGF8 WDR6 SLC12A7	1.98e-05	504	250	14	34432599
Pubmed	Neuromuscular junction immaturity and muscle atrophy are hallmarks of the ColQ-deficient mouse, a model of congenital myasthenic syndrome with acetylcholinesterase deficiency.	MYH1 MYH4 HSPG2	2.00e-05	8	250	3	26993635
Pubmed	Disruption of KCC2 reveals an essential role of K-Cl cotransport already in early synaptic inhibition.	GPHN SLC12A4 SLC12A7	2.00e-05	8	250	3	11395011
Pubmed	DNA methyltransferase 3b regulates articular cartilage homeostasis by altering metabolism.	TET2 DNMT1 TET1	2.00e-05	8	250	3	28614801
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	TET2 MYCBP2 IFT172 HNRNPF FN3K STAB1 SH3YL1 DIP2A PSMG2 PKD1 ARHGAP21 DNMT1 DOCK3 ATRN ITCH VWF ANK2 CORO2A DYNC2I1 DNAAF9 CPNE5 DHX30 METTL8 LTBP3	2.15e-05	1285	250	24	35914814
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	MYCBP2 LEMD3 UNC5B PLXNB2 ME2 MET DIP2A COCH POP1 NOP2 DNMT1 ITCH ANK2 NUP107 WWP2 RALGAPB KIF16B ZDHHC5 SLC6A15 STT3B DHX30 IGF2R WDR6 NUP133 SLC7A5 PLCH1	2.96e-05	1487	250	26	33957083
Pubmed	TET1 regulates fibroblast growth factor 8 transcription in gonadotropin releasing hormone neurons.	TET2 DNMT1 TET1	2.99e-05	9	250	3	31361780
Pubmed	In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.	CD55 CKB SPON2 UMOD ATRN HSPG2 ITCH KRT84 WWP2 STEAP4 SI GRN APRT CPNE5 TGM2 CORO1A RETN IGF2R MEGF8 GAA CDH15	3.54e-05	1070	250	21	23533145
Pubmed	Defining the membrane proteome of NK cells.	MYCBP2 TYSND1 HNRNPF CLCN5 PARP9 MTCH2 MED12 ITCH NUP107 APMAP WWP2 PHRF1 ZDHHC5 PARP14 STT3B CORO1A IGF2R GTF3C1 NUP133 SLC7A5 HCFC1 GAA	4.23e-05	1168	250	22	19946888
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	MYCBP2 RPS27 HNRNPF HNRNPH3 KLHL9 PSME4 NOP2 MED12 SEC23A TBCD CKMT1A NUP107 APMAP RPS27L DHX30 SLC25A22 GTF3C1 WDR6 SLC25A1 NUP133 AGK SLC7A5 HCFC1	4.40e-05	1257	250	23	37317656
Pubmed	Role of the E3 ubiquitin ligase RNF157 as a novel downstream effector linking PI3K and MAPK signaling pathways to the cell cycle.	ATRN MEGF8 PRPF4 SLC25A1	4.66e-05	28	250	4	28655764
Pubmed	Harnessing host enhancers of SARS-CoV-2 entry as novel targets for antiviral therapy.	CD55 PLXNB2 MET IGF2R SLC7A5	4.78e-05	55	250	5	38945485
Pubmed	Distributive Processing by the Iron(II)/α-Ketoglutarate-Dependent Catalytic Domains of the TET Enzymes Is Consistent with Epigenetic Roles for Oxidized 5-Methylcytosine Bases.	TET2 TET1	5.15e-05	2	250	2	27362828
Pubmed	Stage-specific roles for tet1 and tet2 in DNA demethylation in primordial germ cells.	TET2 TET1	5.15e-05	2	250	2	23415914
Pubmed	Itch E3 ubiquitin ligase positively regulates TGF-β signaling to EMT via Smad7 ubiquitination.	ITCH SMAD7	5.15e-05	2	250	2	25518932
Pubmed	Granzyme A: the road less traveled.	APEX1 GZMA	5.15e-05	2	250	2	12555094
Pubmed	Identification of risk genes for autism spectrum disorder through copy number variation analysis in Austrian families.	GPHN DIP2A	5.15e-05	2	250	2	24643514
Pubmed	Attenuation of Excess TNF-α Release in Crohn's Disease by Silencing of iRHOMs 1/2 and the Restoration of TGF-β Mediated Immunosuppression Through Modulation of TACE Trafficking.	RHBDF1 RHBDF2	5.15e-05	2	250	2	35585977
Pubmed	Identification of Tazarotenic Acid as the First Xenobiotic Substrate of Human Retinoic Acid Hydroxylase CYP26A1 and CYP26B1.	CYP26A1 CYP26B1	5.15e-05	2	250	2	26937021
Pubmed	Elimination of redundant synaptic inputs in the absence of synaptic strengthening.	GRIA3 GRIA4	5.15e-05	2	250	2	22090494
Pubmed	Early Expression of Tet1 and Tet2 in Mouse Zygotes Altered DNA Methylation Status and Affected Embryonic Development.	TET2 TET1	5.15e-05	2	250	2	35955629
Pubmed	PCSK9 and resistin at the crossroads of the atherogenic dyslipidemia.	PCSK9 RETN	5.15e-05	2	250	2	24134510
Pubmed	Selection on cis-regulatory variation at B4galnt2 and its influence on von Willebrand factor in house mice.	VWF B4GALNT2	5.15e-05	2	250	2	19088380
Pubmed	Defective bone morphogenic protein signaling underlies hepcidin deficiency in HFE hereditary hemochromatosis.	SMAD6 SMAD7	5.15e-05	2	250	2	20658468
Pubmed	Distinct roles of the methylcytosine oxidases Tet1 and Tet2 in mouse embryonic stem cells.	TET2 TET1	5.15e-05	2	250	2	24474761
Pubmed	Genes adapt to outsmart gene-targeting strategies in mutant mouse strains by skipping exons to reinitiate transcription and translation.	RHBDF1 RHBDF2	5.15e-05	2	250	2	32646486
Pubmed	Tissue plasminogen activator is a ligand of cation-independent mannose 6-phosphate receptor and consists of glycoforms that contain mannose 6-phosphate.	PLAT IGF2R	5.15e-05	2	250	2	33859256
Pubmed	Growth and muscle defects in mice lacking adult myosin heavy chain genes.	MYH1 MYH4	5.15e-05	2	250	2	9382868
Pubmed	Architectural nucleoporins Nup157/170 and Nup133 are structurally related and descend from a second ancestral element.	NUP107 NUP133	5.15e-05	2	250	2	19674973
Pubmed	Expressions of inhibitory Smads, Smad6 and Smad7, are differentially regulated by TPA in human lung fibroblast cells.	SMAD6 SMAD7	5.15e-05	2	250	2	15033458
Pubmed	A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk.	SMAD6 SMAD7	5.15e-05	2	250	2	17934461
Pubmed	Different binding properties and function of CXXC zinc finger domains in Dnmt1 and Tet1.	DNMT1 TET1	5.15e-05	2	250	2	21311766
Pubmed	Biallelic Mutations in Nuclear Pore Complex Subunit NUP107 Cause Early-Childhood-Onset Steroid-Resistant Nephrotic Syndrome.	NUP107 NUP133	5.15e-05	2	250	2	26411495
Pubmed	Association study between novel CYP26 polymorphisms and the risk of betel quid-related malignant oral disorders.	CYP26A1 CYP26B1	5.15e-05	2	250	2	25839051
Pubmed	Undetectable histone O-GlcNAcylation in mammalian cells.	TET2 HCFC1	5.15e-05	2	250	2	26075789
Pubmed	Interleukin-37 protects against acinar cell pyroptosis in acute pancreatitis.	IL37 GSDMD	5.15e-05	2	250	2	36166295
Pubmed	Coordinated increase in inhibitory and excitatory synapses onto retinal ganglion cells during development.	GPHN NLGN2	5.15e-05	2	250	2	21864334
Pubmed	Smad7 Binds Differently to Individual and Tandem WW3 and WW4 Domains of WWP2 Ubiquitin Ligase Isoforms.	WWP2 SMAD7	5.15e-05	2	250	2	31546607
Pubmed	Altered expression and localization of creatine kinase B, heterogeneous nuclear ribonucleoprotein F, and high mobility group box 1 protein in the nuclear matrix associated with colon cancer.	HNRNPF CKB	5.15e-05	2	250	2	16424007
Pubmed	Control of kinetic properties of AMPA receptor channels by nuclear RNA editing.	GRIA3 GRIA4	5.15e-05	2	250	2	7992055
Pubmed	Repression of Dok7 expression mediated by DNMT1 promotes glioma cells proliferation.	DNMT1 DOK7	5.15e-05	2	250	2	29990858
Pubmed	Structural and functional analysis of Nup133 domains reveals modular building blocks of the nuclear pore complex.	NUP107 NUP133	5.15e-05	2	250	2	15557116
Pubmed	Redox-active quinones induces genome-wide DNA methylation changes by an iron-mediated and Tet-dependent mechanism.	TET2 TET1	5.15e-05	2	250	2	24214992
Pubmed	Beta-cell-specific ablation of the hepatocyte growth factor receptor results in reduced islet size, impaired insulin secretion, and glucose intolerance.	MET LTBP3	5.15e-05	2	250	2	16049329
Pubmed	Ten-eleven translocation protein 1 modulates medulloblastoma progression.	TET2 TET1	5.15e-05	2	250	2	33926529
Pubmed	Coordination of engineered factors with TET1/2 promotes early-stage epigenetic modification during somatic cell reprogramming.	TET2 TET1	5.15e-05	2	250	2	24672749
Pubmed	Tet1 regulates epigenetic remodeling of the pericentromeric heterochromatin and chromocenter organization in DNA hypomethylated cells.	DNMT1 TET1	5.15e-05	2	250	2	34166371
Pubmed	Tet1 and Tet2 Protect DNA Methylation Canyons against Hypermethylation.	TET2 TET1	5.15e-05	2	250	2	26598602
Pubmed	Absence seizures in C3H/HeJ and knockout mice caused by mutation of the AMPA receptor subunit Gria4.	GRIA3 GRIA4	5.15e-05	2	250	2	18316356
Pubmed	Coordinate control of axon defasciculation and myelination by laminin-2 and -8.	LAMA2 LAMA4	5.15e-05	2	250	2	15699217
Pubmed	Combined Loss of Tet1 and Tet2 Promotes B Cell, but Not Myeloid Malignancies, in Mice.	TET2 TET1	5.15e-05	2	250	2	26586431
Pubmed	Flanking sequences influence the activity of TET1 and TET2 methylcytosine dioxygenases and affect genomic 5hmC patterns.	TET2 TET1	5.15e-05	2	250	2	35075236
Pubmed	Ca2+ -regulated secretion of tissue-type plasminogen activator and von Willebrand factor in human endothelial cells.	PLAT VWF	5.15e-05	2	250	2	12445472
Pubmed	Ten-Eleven Translocation 1 and 2 Confer Overlapping Transcriptional Programs for the Proliferation of Cultured Adult Neural Stem Cells.	TET2 TET1	5.15e-05	2	250	2	27778125
Pubmed	Cloning of a novel retinoic-acid metabolizing cytochrome P450, Cyp26B1, and comparative expression analysis with Cyp26A1 during early murine development.	CYP26A1 CYP26B1	5.15e-05	2	250	2	11520679
Pubmed	Prognostic value of the expression of Smad6 and Smad7, as inhibitory Smads of the TGF-beta superfamily, in esophageal squamous cell carcinoma.	SMAD6 SMAD7	5.15e-05	2	250	2	15736400
Pubmed	Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism.	TET2 TET1	5.15e-05	2	250	2	28783731
Pubmed	Novel Epigenetic Controlling of Hypoxia Pathway Related to Overexpression and Promoter Hypomethylation of TET1 and TET2 in RPE Cells.	TET2 TET1	5.15e-05	2	250	2	28252217
Pubmed	Knockdown of DNMT1 Induces SLCO3A1 to Promote Follicular Growth by Enhancing the Proliferation of Granulosa Cells in Mammals.	SLCO3A1 DNMT1	5.15e-05	2	250	2	38473715
Pubmed	GluA4 is indispensable for driving fast neurotransmission across a high-fidelity central synapse.	GRIA3 GRIA4	5.15e-05	2	250	2	21690196
Pubmed	Decrease of 5-hydroxymethylcytosine and TET1 with nuclear exclusion of TET2 in small intestinal neuroendocrine tumors.	TET2 TET1	5.15e-05	2	250	2	30045709
Pubmed	Purification, crystallization and preliminary X-ray analysis of a Nup107-Nup133 heterodimeric nucleoporin complex.	NUP107 NUP133	5.15e-05	2	250	2	17768364
Pubmed	Application of a global proteomic approach to archival precursor lesions: deleted in malignant brain tumors 1 and tissue transglutaminase 2 are upregulated in pancreatic cancer precursors.	DMBT1 TGM2	5.15e-05	2	250	2	18849643
Pubmed	Neddylation modification of ribosomal protein RPS27L or RPS27 by MDM2 or NEDP1 regulates cancer cell survival.	RPS27 RPS27L	5.15e-05	2	250	2	32779270
Interaction	TOP3B interactions	TBC1D9B HDAC4 MYCBP2 MFHAS1 OBSCN EML2 PLXNB2 ZDHHC8 ADCY7 ESRP2 DIP2A LMAN2L PSME4 PKD1 NLGN2 NOP2 METTL27 ARHGAP21 MED12 SEC23A TBCD DOCK3 HSPG2 RHBDF1 RHBDF2 ZNF316 ZDHHC5 ADGRL1 GRN APRT C8orf58 FAM83H DHX30 SLC25A22 SCAP IGF2R SLC12A4 MEGF8 SLC7A5 LTBP3 MAPKBP1 HCFC1 SMAD7	3.04e-08	1470	239	43	int:TOP3B
Interaction	RHOJ interactions	LEMD3 UNC5B SLCO3A1 PLXNB2 ZDHHC8 MET DIP2A ARHGAP21 ITCH WWP2 RALGAPB ZDHHC5 ADGRL1 SLC6A15 STT3B DHX30 IGF2R SLC12A4 WDR6 SLC25A1 SLC7A5 SLC12A7	7.10e-06	633	239	22	int:RHOJ
Interaction	RHOU interactions	UNC5B ZKSCAN7 PLXNB2 ZDHHC8 LANCL2 MET INSM2 ITCH WWP2 RALGAPB ZDHHC5 SLC6A15 IGF2R BRF1 SLC12A4 WDR6 SLC25A1 SLC7A5 SLC12A7	1.17e-05	510	239	19	int:RHOU
Interaction	RHOQ interactions	LEMD3 UNC5B PLXNB2 ZDHHC8 ARHGAP21 CDC42BPG ITCH WWP2 RALGAPB ZDHHC5 SLC6A15 IGF2R SLC12A4 WDR6 SLC25A1 SLC7A5 SLC12A7	2.29e-05	442	239	17	int:RHOQ
GeneFamily	Solute carriers	SLCO3A1 SLC9B2 SLC37A2 SLC49A3 SLC35E4 SLC23A2 MTCH2 SLC6A15 SLC22A12 SLC25A22 SLC7A3 SLC12A4 SLC2A6 SLC25A1 SLC15A5 SLC7A5 SLC25A47 SLC12A7 SLC16A8	2.75e-09	395	162	19	752
GeneFamily	WD repeat domain containing	IFT172 EML2 DCAF4L2 DYNC2I2 CORO2A DYNC2I1 CORO1A SCAP PRPF4 WDR6 MAPKBP1	2.49e-05	262	162	11	362
GeneFamily	Cytochrome P450 family 26	CYP26A1 CYP26B1	2.38e-04	3	162	2	1013
GeneFamily	Myosin heavy chains	MYH1 MYH4 MYH13	2.97e-04	15	162	3	1098
GeneFamily	Glutamate ionotropic receptor AMPA type subunits	GRIA3 GRIA4	4.73e-04	4	162	2	1200
GeneFamily	WD repeat domain containing\|Coronins	CORO2A CORO1A	1.63e-03	7	162	2	495
GeneFamily	SMAD family	SMAD6 SMAD7	2.16e-03	8	162	2	750
GeneFamily	Transglutaminases	TGM2 EPB42	2.76e-03	9	162	2	773
GeneFamily	Plexins	PLXNB2 PLXNA2	2.76e-03	9	162	2	683
GeneFamily	Chloride voltage-gated channels	CLCN5 CLCNKB	3.43e-03	10	162	2	302
GeneFamily	Zinc fingers CXXC-type	DNMT1 TET1	4.96e-03	12	162	2	136
GeneFamily	Laminin subunits	LAMA2 LAMA4	4.96e-03	12	162	2	626
Coexpression	GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP	HDAC4 MFHAS1 CD55 BCOR ADCY7 GRIA3 TET1 METTL8 SLC12A7 SMAD7	2.06e-06	152	249	10	M2938
Coexpression	CHEN_METABOLIC_SYNDROM_NETWORK	HK3 MFHAS1 ARL11 UNC5B SLCO3A1 PLXNB2 ME2 ADCY7 FN3K STAB1 CLCN5 CLCNKB SGPL1 SLC37A2 PLAT ARHGAP25 NLGN2 SLC35E4 DNMT1 RHBDF1 PRICKLE1 LAMA2 GRN CORO1A CD22 SLC2A6 GSDMD HAGH LTBP3 RPE65	2.80e-06	1242	249	30	M1920
Coexpression	GSE13946_CTRL_VS_DSS_COLITIS_GD_TCELL_FROM_COLON_DN	HDAC4 CD55 BCOR SI GRIA3 TSPAN32 TET1 AGK METTL8 SLC12A7	5.61e-06	170	249	10	M2942
Coexpression	GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_UP	HDAC4 ATRN CACNB2 ADGRL1 SI GRIA3 TSPAN32 STT3B TET1 SLC12A7	6.23e-06	172	249	10	M2945
Coexpression	CHEN_METABOLIC_SYNDROM_NETWORK	HK3 MFHAS1 ARL11 UNC5B SLCO3A1 PLXNB2 ME2 ADCY7 FN3K STAB1 CLCN5 CLCNKB SGPL1 SLC37A2 PLAT ARHGAP25 NLGN2 SLC35E4 DNMT1 RHBDF1 PRICKLE1 LAMA2 GRN CORO1A CD22 SLC2A6 GSDMD HAGH LTBP3 RPE65	8.73e-06	1316	249	30	MM1052
Coexpression	MILI_PSEUDOPODIA_CHEMOTAXIS_DN	MATN4 PLXNB2 SGPL1 PKD1 PLAT SLC23A2 MTCH2 ATRN WWP2 ZDHHC5 GRN DNAAF9 DHX30 SLC12A4 GAA MSLN	8.78e-06	457	249	16	M1613
Coexpression	NABA_CORE_MATRISOME	MATN4 COCH SPON2 DMBT1 HSPG2 COL8A2 VWF LAMA2 LAMA4 BCAN SLIT1 LTBP3	1.17e-05	270	249	12	MM17057
Coexpression	MILI_PSEUDOPODIA_CHEMOTAXIS_DN	MATN4 PLXNB2 SGPL1 PKD1 PLAT SLC23A2 MTCH2 ATRN WWP2 ZDHHC5 GRN DNAAF9 DHX30 SLC12A4 GAA MSLN	1.24e-05	470	249	16	MM1053
Coexpression	NABA_CORE_MATRISOME	MATN4 COCH SPON2 DMBT1 HSPG2 COL8A2 VWF LAMA2 LAMA4 BCAN SLIT1 LTBP3	1.40e-05	275	249	12	M5884
Coexpression	LIM_MAMMARY_STEM_CELL_UP	MYLK HDAC4 SLCO3A1 BCOR FBXO30 TMEM178A PKD1 ARHGAP25 NLGN2 PLXNA2 HSPG2 PRICKLE1 ADGRL1 TAMALIN SLC12A4 LGR6	1.57e-05	479	249	16	M2573
Coexpression	LIM_MAMMARY_STEM_CELL_UP	MYLK HDAC4 SLCO3A1 BCOR FBXO30 TMEM178A PKD1 ARHGAP25 NLGN2 PLXNA2 HSPG2 PRICKLE1 ADGRL1 TAMALIN SLC12A4 LGR6	1.74e-05	483	249	16	MM1082
Coexpression	FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_DN	HK3 SLCO3A1 STAB1 IL1R2 SLC37A2 SLC49A3 VWF GRN IGF2R	6.21e-05	181	249	9	M40912
Coexpression	CUI_TCF21_TARGETS_2_UP	NFATC4 SESN2 NLGN2 COL8A2 DYNC2I2 LAMA2 LAMA4 APEX1 GRIA3 APRT CPNE5 TGM2 TET1 PLCH1	8.34e-05	437	249	14	M1610
Coexpression	NABA_ECM_GLYCOPROTEINS	MATN4 COCH SPON2 DMBT1 VWF LAMA2 LAMA4 SLIT1 LTBP3	9.38e-05	191	249	9	MM17059
Coexpression	NABA_ECM_GLYCOPROTEINS	MATN4 COCH SPON2 DMBT1 VWF LAMA2 LAMA4 SLIT1 LTBP3	1.14e-04	196	249	9	M3008
Coexpression	GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IFNAB_CD8_TCELL_UP	SLCO3A1 RPS27 SGPL1 PKD1 PHRF1 GRIA3 GZMA METTL8 SLC12A7	1.23e-04	198	249	9	M3601
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HENDO	UNC5B CD55 STAB1 ERC2-IT1 PARP9 HSPG2 VWF RHBDF2 PGGHG LAMA4 GRN APRT PARP14 CPNE5 TAMALIN TGM2 GZMA GPCPD1 SLC7A5 SMAD6 SMAD7	1.26e-04	888	249	21	M39049
Coexpression	CUI_TCF21_TARGETS_2_UP	NFATC4 SESN2 NLGN2 COL8A2 DYNC2I2 LAMA2 LAMA4 APEX1 GRIA3 APRT CPNE5 TGM2 TET1 PLCH1	1.27e-04	455	249	14	MM1189
Coexpression	GSE26669_CD4_VS_CD8_TCELL_IN_MLR_DN	UMOD METTL27 ITCH IDH3A IGF2R TIRAP SV2C OXNAD1 PAX1	1.28e-04	199	249	9	M4670
Coexpression	CHYLA_CBFA2T3_TARGETS_DN	MFHAS1 FN3K SESN2 FAM234B ZNF316 DYNC2I1 IGF2R SLC12A4 METTL8 EPB42	1.31e-04	246	249	10	M2206
Coexpression	GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_DN	SLCO3A1 ARHGAP25 SESN2 ITCH RHBDF2 APMAP WWP2 GZMA SMAD7	1.33e-04	200	249	9	M4656
Coexpression	GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_PLASMA_CELL_DAY7_UP	MYCBP2 LMAN2L NFATC4 POP1 SLC9B2 PARP9 NAT14 SLC7A3 SLC7A5	1.33e-04	200	249	9	M9360
Coexpression	GSE9650_NAIVE_VS_EFF_CD8_TCELL_UP	MYCBP2 MFHAS1 PKD1 APEX1 DHX30 WDR6 HAGH SLC12A7 SMAD7	1.33e-04	200	249	9	M5819
Coexpression	GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_UP	SGPL1 PKD1 PHRF1 ZDHHC5 ADGRL1 GRIA3 IDH3A TGM2 GZMA	1.33e-04	200	249	9	M3605
Coexpression	GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_DN	TYSND1 POP1 METTL16 PLXNA2 LAMA2 IGF2R SLC12A4 PRPF4 OXNAD1	1.33e-04	200	249	9	M7492
Coexpression	GSE37301_MULTIPOTENT_PROGENITOR_VS_PRO_BCELL_UP	SLCO3A1 ESRP2 HOXD1 NOP2 ADGRL1 FAM83H CD22 TET1 B4GALNT2	1.33e-04	200	249	9	M8843
Coexpression	GSE23505_IL6_IL1_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP	TBC1D9B MYCBP2 MFHAS1 CKB GPT2 RHBDF1 DYNC2I2 CD22 GSDMD	1.33e-04	200	249	9	M7872
ToppCell	E16.5-samps-Mesenchymal-Myofibroblast\|E16.5-samps / Age Group, Lineage, Cell class and subclass	MYLK CKB SPON2 PLXNA2 CACNB2 ANK2 LAMA2 LTBP3 LGR6 MEGF10	1.06e-07	186	250	10	e044b3428b7eacfdc72d0f57cdabaa1de04c74cd
ToppCell	367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	SPON2 ADAMTS15 ARHGAP25 NLGN2 APMAP VXN IGF2R GTF3C1 GZMA	3.18e-07	160	250	9	955acb023ce4ccfac5073c9d693db87db3856187
ToppCell	droplet-Fat-Gat-18m-Mesenchymal-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MATN4 NEGR1 KCTD5 PLAT METTL27 SEC23A AOX1 DYNC2I1	8.27e-07	132	250	8	4152529611eeacf0c547e2a134d5b98c45426b13
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RYR2 PLAT NEURL1B PLXNA2 TBCD HSPG2 VWF CYP26B1 TAMALIN	9.81e-07	183	250	9	dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RYR2 PLAT NEURL1B PLXNA2 TBCD HSPG2 VWF CYP26B1 TAMALIN	9.81e-07	183	250	9	4759560e5b4f4e5a00e5f933e3451a27c7c4aefe
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	UNC5B STAB1 COCH SLC37A2 VWF CYP26B1 HACL1 HAGH SMAD6	1.07e-06	185	250	9	87151ab95530e70d61328b336518df58db584acb
ToppCell	droplet-Lung-LUNG-1m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LDLRAD2 FN3K COCH PLAT HSPG2 VWF CYP26B1 TAMALIN SMAD6	1.12e-06	186	250	9	1e67bfb248366d7395efdd2d5e70a97bdb2e68af
ToppCell	metastatic_Lymph_Node-T/NK_cells-Cytotoxic_CD8+_T\|metastatic_Lymph_Node / Location, Cell class and cell subclass	RPS27 DIP2A SPON2 ARHGAP25 APMAP TSPAN32 CORO1A IGF2R GZMA	1.59e-06	194	250	9	73c057b623829de793616d9d373a0018071d51d8
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYLK CKB TMEM178A SPON2 ADAMTS15 PLXNA2 LAMA2 LAMA4 LGR6	1.66e-06	195	250	9	2414b158dc7bdec43a9671544bfb7ffc5f5168fd
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYLK CKB TMEM178A SGPL1 SPON2 ADAMTS15 PLXNA2 LAMA2 MEGF10	1.66e-06	195	250	9	b0d408f8bc1701a87596ed55efcd90749fee33e6
ToppCell	E17.5-Mesenchymal-myocytic_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MYLK CKB TMEM178A SPON2 PLXNA2 CACNB2 ANK2 LGR6 MEGF10	1.66e-06	195	250	9	01a750d660993017af00736215cbcff2de5909c1
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYLK CKB TMEM178A SGPL1 SPON2 ADAMTS15 PLXNA2 LAMA2 MEGF10	1.66e-06	195	250	9	a486a7acea0e91048cc48afa0dbd3926d30bc217
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYLK DGKB RYR2 NEGR1 DOCK3 CACNB2 LAMA4 CPNE5 LGR6	1.73e-06	196	250	9	9830fb3da7a60f65ad463e9054bb77c06b025e4d
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYLK DGKB RYR2 CKB NEGR1 DOCK3 CACNB2 LAMA4 LGR6	1.81e-06	197	250	9	ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYLK DGKB RYR2 CKB NEGR1 DOCK3 CACNB2 LAMA4 LGR6	1.88e-06	198	250	9	c12e7511628db819a52959bb68580e27c00c2e41
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYLK DGKB RYR2 CKB NEGR1 DOCK3 CACNB2 LAMA4 LGR6	1.88e-06	198	250	9	22e766df1276c5b14aa0d83f434f47140ebb98ea
ToppCell	E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_A\|E18.5-samps / Age Group, Lineage, Cell class and subclass	UGT2A2 CKB SPON2 ADAMTS15 SLC49A3 TMPRSS9 LGR6 MEGF10	1.96e-06	148	250	8	5729826e8d45bf995e2efa6707c49e264d12d112
ToppCell	LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TET2 HK3 BCOR SLC37A2 STEAP4 FAM83H SLC25A22 SLC2A6	3.50e-06	160	250	8	5d8d97c3da5837ba5fe743d2f8438f5cb7cea64b
ToppCell	facs-Lung-EPCAM-24m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD55 RPS27 PKDREJ PCSK9 TSPAN32 CORO1A CD22 SLC15A5	4.81e-06	167	250	8	691f3589de0f8c13f9137812cfa9040c07d237b4
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_NK-NK_CD16\|GI_small-bowel / Manually curated celltypes from each tissue	DIP2A DMBT1 OVCA2 APMAP LINC00299 TAMALIN IGF2R GTF3C1	5.98e-06	172	250	8	701de463f85aaad3a4b36a0d5fbc416406620089
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK MET TMEM178A PCSK9 COL8A2 ANK2 DOK7 TFAP2B	6.51e-06	174	250	8	46bd0ef7d0541386de7a901d85d53d0176dc92bf
ToppCell	wk_20-22-Endothelial-Blood_vessel_endothelial-OMD+_endo\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	MET HSPG2 VWF CYP26B1 ASB12 TGM2 LTBP3 SMAD6	7.07e-06	176	250	8	52af8f717dbd3b59eeb868b8b7b256a8f3e57d7a
ToppCell	facs-Lung-3m-Epithelial-airway_epithelial-respiratory_basal_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZKSCAN7 CKMT1A DOK7 SLC6A15 FAM83H LGR6 CDH15 MSLN	7.68e-06	178	250	8	fb8f8d95f6b08378fb42c4076ee040276faa296f
ToppCell	facs-Lung-3m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_bronchioalveolar_tree\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZKSCAN7 CKMT1A DOK7 SLC6A15 FAM83H LGR6 CDH15 MSLN	7.68e-06	178	250	8	b89c4d015b44bf538aa39969ef8778877c8023f1
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	OBSCN RYR2 DOCK3 CACNB2 NRAP ANK2 LAMA2 CPNE5	1.02e-05	185	250	8	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	droplet-Limb_Muscle-nan-24m-Mesenchymal-skeletal_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 MYH4 OBSCN GPT2 NRAP IDH3A ASB12 SLC15A5	1.02e-05	185	250	8	9245c322aae8bb9065d50dada198a5ee143a3444
ToppCell	PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	MYLK UNC5B CKB SPON2 PLAT ANK2 LGR6 MEGF10	1.02e-05	185	250	8	427176ad9ab8d9511200fb0a132cfd1e835fe35c
ToppCell	droplet-Lung-1m-Endothelial-arterial_endothelial\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LDLRAD2 FN3K COCH PLAT HSPG2 VWF CYP26B1 SMAD6	1.06e-05	186	250	8	ffbc78058be8f0dc2e0335cc4c3195a636d17721
ToppCell	droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LDLRAD2 FN3K COCH PLAT HSPG2 VWF CYP26B1 SMAD6	1.06e-05	186	250	8	ed924852cd7132c8f6703522037dc22bd2c83193
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	MYCBP2 SLC6A15 CPNE5 SLC7A3 WDR6 SV2C GRIP2 GAA	1.14e-05	188	250	8	b73e8a40393c3f656e2fcfe395a761b1f985c254
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	SPON2 APMAP TSPAN32 GTF3C1 TET1 GZMA LGR6 ATP2B3	1.19e-05	189	250	8	bed43041e6f8ba19787150a6aaa492f2656135d9
ToppCell	(2)_NK/T-(21)_NKT_cell\|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization)	FN3K DIP2A SPON2 APMAP IGF2R GTF3C1 GZMA SLC12A7	1.19e-05	189	250	8	b37ad24898a14a4a3b2d6cea2637de2471f76e20
ToppCell	(2)_NK/T-(210)_NKT_cell\|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization)	FN3K DIP2A SPON2 APMAP IGF2R GTF3C1 GZMA SLC12A7	1.19e-05	189	250	8	fa72e87e1e8cd7cbddae7b47e19cf90d181820a7
ToppCell	Control-Lymphoid-NK\|Lymphoid / Disease state, Lineage and Cell class	DIP2A SPON2 APMAP LINC00299 TAMALIN IGF2R GTF3C1 GZMA	1.24e-05	190	250	8	1584c68b58c7f406d9b0e8451beea3e6f8980c56
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	MYLK RYR2 NEGR1 CACNB2 ANK2 AOX1 LAMA2 LAMA4	1.24e-05	190	250	8	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	hematopoetic_progenitors-CD34+_CLP\|hematopoetic_progenitors / Lineage and Cell class	MYLK NEGR1 TBCD AOX1 CORO1A IGF2R CD22 SMAD7	1.24e-05	190	250	8	117abdafd294c85ccb5d8ea907e3c0491b7200b2
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	OBSCN RYR2 PSME4 CACNB2 NRAP ANK2 LAMA2 CPNE5	1.24e-05	190	250	8	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	OBSCN RYR2 FN3K CACNB2 ANK2 LAMA2 CPNE5 GRIP2	1.24e-05	190	250	8	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYLK RYR2 NEGR1 CACNB2 ANK2 AOX1 LAMA2 LAMA4	1.28e-05	191	250	8	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYLK RYR2 CKB NEGR1 DOCK3 CACNB2 GRIA3 LGR6	1.33e-05	192	250	8	992d08092edbc68c47b945deb8708379738c239a
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYLK RYR2 NEGR1 CACNB2 ANK2 AOX1 LAMA2 LAMA4	1.33e-05	192	250	8	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell\|Adult / Lineage, Cell type, age group and donor	NFATC4 NEGR1 PLAT CACNB2 ANK2 AOX1 LAMA2 LAMA4	1.33e-05	192	250	8	d21f0f577156f17c899b08871046a26b88aea011
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CYP26A1 DGKB CSMD3 SPON2 PLAT CACNB2 CYP26B1 CD22	1.38e-05	193	250	8	cd45118ced91b10baed3b1068d4673ec99824b86
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	DIP2A SPON2 APMAP DOK7 LINC00299 IGF2R GTF3C1 GZMA	1.38e-05	193	250	8	b53ffef20f918b7d1e9d3924562691d13245e2dd
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYLK RYR2 NEGR1 ADAMTS15 CACNB2 AOX1 LAMA2 LAMA4	1.38e-05	193	250	8	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DGKB PKDREJ SPON2 SLC9B2 ADAMTS15 LAMA2 STEAP4 LTBP3	1.44e-05	194	250	8	7826fe5eb254ac032de0d978f39585a40e0b3ee4
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYLK RYR2 ADAMTS15 CACNB2 RHBDF1 AOX1 LAMA2 LAMA4	1.44e-05	194	250	8	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LANCL2 CKB TMEM178A NAT14 LAMA2 GRIA3 GRIA4 CDH15	1.44e-05	194	250	8	8b81f039f5b25d35a4d5a41b27d4d9360ba22f15
ToppCell	E17.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MYLK CKB SPON2 PLXNA2 CACNB2 ANK2 LGR6 MEGF10	1.49e-05	195	250	8	1daddd801bd4596fffbdb822fc326d5127c96004
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PLAT PLXNA2 HSPG2 VWF CPNE5 TAMALIN TGM2 SMAD6	1.55e-05	196	250	8	4cd1e6b7a791e11a40b19f971b7011bd11fe6273
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PLAT PLXNA2 HSPG2 VWF CPNE5 TAMALIN TGM2 SMAD6	1.55e-05	196	250	8	d37f714d4fb57e958f3738fdda085560813e5bb5
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYLK RYR2 NEGR1 ADAMTS15 CACNB2 AOX1 LAMA2 LAMA4	1.55e-05	196	250	8	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYLK RYR2 NEGR1 CACNB2 ANK2 AOX1 LAMA2 LAMA4	1.55e-05	196	250	8	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYLK NEGR1 SPON2 CACNB2 LAMA2 LAMA4 BCAN ATP2B3	1.61e-05	197	250	8	44673c38384453207871d3fd8e8ba9093cc06bc5
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-IPC_like-IPCs\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	CYP26A1 RPS27 CKB NEURL1B PLXNA2 VXN SLC6A15 RPS27L	1.66e-05	198	250	8	b3488e916fff9a4ff62eb897d3783c93296dbd65
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	MET CLCN5 ANK2 LAMA2 GRIA4 TET1 MEGF10 CDH15	1.66e-05	198	250	8	55e583321f60c95898d93cd0d2615c6692db52ec
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	MYLK RYR2 NEGR1 CACNB2 ANK2 AOX1 LAMA2 LAMA4	1.66e-05	198	250	8	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	MYLK RYR2 NEGR1 CACNB2 ANK2 AOX1 LAMA2 LAMA4	1.66e-05	198	250	8	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-IPC_like\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	CYP26A1 RPS27 CKB NEURL1B PLXNA2 VXN SLC6A15 RPS27L	1.66e-05	198	250	8	6d99901d4df24eb3c5cca80afd9a81eb7ee8fcf1
ToppCell	Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MET PLAT VWF GRN TAMALIN TGM2 SMAD6 SMAD7	1.66e-05	198	250	8	f88198e11e835ad53d339c312f8f7b7b0b5c02d3
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYLK RYR2 NEGR1 CACNB2 ANK2 AOX1 LAMA2 LAMA4	1.66e-05	198	250	8	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	MET CLCN5 ANK2 LAMA2 GRIA4 TET1 MEGF10 CDH15	1.73e-05	199	250	8	e19b296d583f8bad3b66ee998a8153634d6fe09e
ToppCell	distal-Hematologic-Natural_Killer-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DIP2A SPON2 APMAP LINC00299 TSPAN32 CORO1A GTF3C1 GZMA	1.73e-05	199	250	8	928b152f3bade90dfdb15e46aaa0c85063db0026
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYLK MYCBP2 SLCO3A1 RYR2 ADAMTS15 ANK2 LAMA4 TGM2	1.73e-05	199	250	8	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_pulmonary_arterial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	HSPG2 VWF CYP26B1 TAMALIN TGM2 GRIP2 SMAD6 SMAD7	1.73e-05	199	250	8	fff88d2bba262583bb726900ae01e44954b72eb9
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	MET CLCN5 ANK2 LAMA2 GRIA4 TET1 MEGF10 CDH15	1.73e-05	199	250	8	801887db51ac5dc5b068808ff75e3a46643398e9
ToppCell	severe\|World / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	HK3 KREMEN1 CD55 PARP9 STEAP4 GRN PARP14 RETN	1.73e-05	199	250	8	c24aacef7405700bc5d0b736a38feea12b7f17c8
ToppCell	Non-neuronal-Postmitotic-Endothelial\|World / Primary Cells by Cluster	UNC5B SPON2 HSPG2 VWF LAMA2 LAMA4 SLC7A5 SLC12A7	1.73e-05	199	250	8	b9763ac9857a60db6f1f104fe1e9ea2266cf931b
ToppCell	Non-neuronal-Postmitotic-Endothelial-Endothelial-24\|World / Primary Cells by Cluster	UNC5B SPON2 HSPG2 VWF LAMA2 LAMA4 SLC7A5 SLC12A7	1.73e-05	199	250	8	0b4edf3e359749827ef978a77b5267ddde732d71
ToppCell	Sepsis-Leuk-UTI-Lymphocyte-T/NK-CD4+_CTL\|Leuk-UTI / Disease, condition lineage and cell class	PKD1L1 ZKSCAN7 RPS27 FN3K SPON2 LAMA2 ZNF252P-AS1 GZMA	1.73e-05	199	250	8	b2609f9d716fdd04f35f0da7f8995d28d7df431d
ToppCell	Non-neuronal-Postmitotic-Endothelial-Endothelial\|World / Primary Cells by Cluster	UNC5B SPON2 HSPG2 VWF LAMA2 LAMA4 SLC7A5 SLC12A7	1.73e-05	199	250	8	9e01eee126247a0696c71b019f855a8a41a0ede3
ToppCell	Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_pulmonary_venous\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	PLAT NEURL1B HSPG2 VWF TAMALIN TGM2 SMAD6 SMAD7	1.73e-05	199	250	8	15db14eff63d5edeced0738542d5fb739225511b
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYLK RYR2 NEGR1 CACNB2 ANK2 AOX1 LAMA2 LAMA4	1.79e-05	200	250	8	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	MYLK RYR2 CKB MET DOCK3 CACNB2 LAMA4 LTBP3	1.79e-05	200	250	8	9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	MFHAS1 NFATC4 PPM1N RHBDF2 SLC12A4 CD22 GSDMD SLC12A7	1.79e-05	200	250	8	25f4c051c2e869481f33c22ad54de97efac444ad
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DIP2A SPON2 APMAP LINC00299 TSPAN32 CORO1A GZMA LGR6	1.79e-05	200	250	8	7d90fcb5dfc4c9d562c93b0f9293ed12b5f4f404
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DIP2A SPON2 APMAP LINC00299 TSPAN32 CORO1A GZMA LGR6	1.79e-05	200	250	8	d2422aaf807010194994db97142b9fd2e807312d
ToppCell	Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IL1R2 NEURL1B VWF CYP26B1 TAMALIN TGM2 SLC2A6 SMAD6	1.79e-05	200	250	8	fe493b0454a20498e9ada482bf55de64519f6c35
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DIP2A SPON2 APMAP LINC00299 TSPAN32 CORO1A GZMA LGR6	1.79e-05	200	250	8	0a6fc7eff94e2f71af9f31a01779aafd2f4a6699
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYLK RYR2 NEGR1 CACNB2 ANK2 AOX1 LAMA2 LAMA4	1.79e-05	200	250	8	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	mild-Classical_Monocyte\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TET2 HK3 SLCO3A1 PLXNB2 STAB1 GRN GPCPD1 GAA	1.79e-05	200	250	8	c8b80d4e7f70c66cbbdd0665821bcd5db69c7d35
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	MYLK MYCBP2 RYR2 ADAMTS15 CACNB2 ANK2 AOX1 LAMA4	1.79e-05	200	250	8	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial-Proteoglycan-expressing_cell\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	MFHAS1 NFATC4 PPM1N RHBDF2 SLC12A4 CD22 GSDMD SLC12A7	1.79e-05	200	250	8	da45a85a4667965b24ba824af871157af5b4cd19
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HK3 STAB1 SLC37A2 RHBDF2 GRN CORO1A RETN GAA	1.79e-05	200	250	8	74ceebee9af63f8b3ec5857eff1b662752bc3862
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYLK RYR2 NFATC4 NEGR1 CACNB2 PRICKLE1 LAMA2 LAMA4	1.79e-05	200	250	8	58b38f9a484ee94191091a0659ed62ebed2d4a14
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m-Macroglial-Glia_progenitor_cell\|3m / Sample Type, Dataset, Time_group, and Cell type.	UNC5B CD55 SESN2 GPT2 BCAN RPS27L TET1 SLC7A5	1.79e-05	200	250	8	c5afba198818d02b4e79956edd7e77ebff74fc2e
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-OPC_related\|6m / Sample Type, Dataset, Time_group, and Cell type.	RPS27 CKB DOK7 APEX1 RPS27L SLIT1 MEGF10 CDH15	1.79e-05	200	250	8	ea1e3eeddbc398ac97863120f7aa3f17569ca12a
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-OPC_related-Oligodendrocyte/OPC\|6m / Sample Type, Dataset, Time_group, and Cell type.	RPS27 CKB DOK7 APEX1 RPS27L SLIT1 MEGF10 CDH15	1.79e-05	200	250	8	4a57f2f2dc6e2402ac4772b5cd38e033a6f1adee
ToppCell	severe-Myeloid-Neutrophils_4\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	HK3 KREMEN1 CD55 IL1R2 APMAP STEAP4 CPNE5 IGF2R	1.79e-05	200	250	8	b665f36dcf3c9d3981ee96f2973512f751612542
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYLK RYR2 NEGR1 CACNB2 ANK2 AOX1 LAMA2 LAMA4	1.79e-05	200	250	8	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Bronchial-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD14\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TET2 HK3 PLCXD1 CD55 STAB1 IL1R2 CORO1A GPCPD1	1.79e-05	200	250	8	1aa4197f1c7c099313dc2e1f8b1153252add7a33
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated\|COVID-19_Mild / Disease, condition lineage and cell class	DIP2A SPON2 ARHGAP25 PARP9 APMAP IGF2R GZMA LGR6	1.79e-05	200	250	8	2281debd86e5d92e8fe0397aec9ef670800f7471
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYLK RYR2 NEGR1 CACNB2 ANK2 AOX1 LAMA2 LAMA4	1.79e-05	200	250	8	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T\|COVID-19_Severe / Disease, condition lineage and cell class	DIP2A SPON2 APMAP LAMA2 GTF3C1 GZMA LGR6 SMAD7	1.79e-05	200	250	8	f72bc3f6606ae77fe1b0a972e35b3ce0727804d9
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DIP2A SPON2 APMAP LINC00299 TSPAN32 CORO1A GZMA LGR6	1.79e-05	200	250	8	1d2ee63010b7b8b38bea7d3b30eebfbcdd18b967
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1-Excitatory_Neuron.Slc17a7.Reln_(Medial_entorrhinal_cortexm,_Reln+/Cbln1+)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MYH4 ABCA12 OBSCN INSM2 USH1C	2.35e-05	61	250	5	5e855b5462f42b7a1d0bbd518cc11072342ce0cc
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1-Excitatory_Neuron.Slc17a7.Reln_(Medial_entorrhinal_cortexm,_Reln+/Cbln1+)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MYH4 ABCA12 OBSCN INSM2 USH1C	2.35e-05	61	250	5	2fc13475581431f82e0b5ef42e18cd29c9787666
ToppCell	Leuk-UTI-Lymphocyte-T_NK-CD4_CTL\|Leuk-UTI / Disease, Lineage and Cell Type	PKD1L1 ZKSCAN7 RPS27 SPON2 LAMA2 ZNF252P-AS1 GZMA	2.67e-05	154	250	7	170a421fd69dba2929568c72e983ae9cfaf2aabc
ToppCell	severe_COVID-19-MAIT\|World / disease group, cell group and cell class (v2)	TNK1 LEMD3 OBSCN GTF3C1 GZMA OXNAD1 SLC7A5	2.67e-05	154	250	7	65ec7f7ef05c589903c4c9fe3849478c325fdc61
ToppCell	5'-Adult-Appendix-Hematopoietic-T_cells-gdT\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TMPRSS9 ZDHHC5 LINC00299 TSPAN32 TET1 GZMA OXNAD1	2.67e-05	154	250	7	d2aa24c593a1c0c6f186b74a18438b64b4e59701
Drug	caffeine	CYP2B6 MYLK PLCXD1 CYP26A1 ADCY7 RYR2 CKB PKD1 SEC23A CKMT1A CACNB2 CYP26B1 WWP2 GRIA3 GRIA4 STT3B B4GALNT2 HAGH PLCH1 ATP2B3 MSLN	8.53e-07	562	245	21	CID000002519
Drug	AC1N9ZZC	MYH1 MYH4 MYH13 UNC5B OBSCN CD55 RYR2 HSPG2 ANK2 LIN28A	5.12e-06	149	245	10	CID004369374
Disease	Schizophrenia	KREMEN1 HDAC4 ME2 ZDHHC8 ADCY7 CKB MET LMAN2L PLAT NLGN2 MSS51 MED12 PLXNA2 DNMT1 CACNB2 LAMA2 GRIA3 GRIA4 GRN TGM2 TET1 HAGH MEGF10	1.31e-06	883	243	23	C0036341
Disease	alkaline phosphatase measurement	TET2 CYP2B6 LDLRAD2 MFHAS1 NGRN NFATC4 PKD1 ARHGAP25 NLGN2 DMBT1 ARHGAP21 DNMT1 HSPG2 PGGHG WWP2 DOK7 KIF16B PKD2L1 SLC2A6 TIRAP LTBP3 SMAD7	3.87e-05	1015	243	22	EFO_0004533
Disease	myopathy (implicated_via_orthology)	MYH1 MYH4 MYH13 CLCNKB MEGF10	4.66e-05	48	243	5	DOID:423 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH1 MYH4 MYH13	6.34e-05	10	243	3	DOID:0111602 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH1 MYH4 MYH13	6.34e-05	10	243	3	DOID:0111596 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH1 MYH4 MYH13	6.34e-05	10	243	3	DOID:0080719 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH1 MYH4 MYH13	6.34e-05	10	243	3	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH1 MYH4 MYH13	6.34e-05	10	243	3	DOID:0111605 (implicated_via_orthology)
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH1 MYH4 MYH13	6.34e-05	10	243	3	DOID:0111269 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH1 MYH4 MYH13	6.34e-05	10	243	3	DOID:0110454 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH1 MYH4 MYH13	6.34e-05	10	243	3	DOID:0080326 (implicated_via_orthology)
Disease	bile duct carcinoma (is_marker_for)	SLC7A5 MSLN	6.75e-05	2	243	2	DOID:4897 (is_marker_for)
Disease	Colorectal Carcinoma	TET2 HK3 ABCA12 OBSCN EML2 CSMD3 FBXO30 HOXD1 ADAMTS15 SESN2 CACNB2 ANK2 TGM2 BRF1 B4GALNT2 LGR6 SMAD7	8.08e-05	702	243	17	C0009402
Disease	Jeune thoracic dystrophy	IFT172 DYNC2I2 DYNC2I1	8.67e-05	11	243	3	C0265275
Disease	myotonia congenita (implicated_via_orthology)	MYH1 MYH4 MYH13	1.15e-04	12	243	3	DOID:2106 (implicated_via_orthology)
Disease	distal myopathy (implicated_via_orthology)	MYH1 MYH4 MYH13	1.15e-04	12	243	3	DOID:11720 (implicated_via_orthology)
Disease	Short Rib-Polydactyly Syndrome	IFT172 DYNC2I2 DYNC2I1	1.48e-04	13	243	3	C0036996
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH1 MYH4 MYH13	1.48e-04	13	243	3	DOID:397 (implicated_via_orthology)
Disease	Majewski Syndrome	IFT172 DYNC2I2 DYNC2I1	1.88e-04	14	243	3	C0024507
Disease	Saldino-Noonan Syndrome	IFT172 DYNC2I2 DYNC2I1	1.88e-04	14	243	3	C0036069
Disease	Bacteremia	PLAT TIRAP	2.02e-04	3	243	2	C0004610
Disease	Cerebral Thrombosis	PLAT VWF	2.02e-04	3	243	2	C0079102
Disease	Congenital myasthenic syndrome ib	DOK7 GRN	2.02e-04	3	243	2	C1850792
Disease	Brain Thrombus	PLAT VWF	2.02e-04	3	243	2	C0936261
Disease	Cerebral Thrombus	PLAT VWF	2.02e-04	3	243	2	C0936263
Disease	Intracranial Thrombosis	PLAT VWF	2.02e-04	3	243	2	C0752143
Disease	Brain Thrombosis	PLAT VWF	2.02e-04	3	243	2	C0752144
Disease	distal arthrogryposis (implicated_via_orthology)	MYH1 MYH4 MYH13	2.33e-04	15	243	3	DOID:0050646 (implicated_via_orthology)
Disease	Tuberculosis	CORO1A TIRAP	4.01e-04	4	243	2	C0041296
Disease	von Willebrand's disease 1 (is_implicated_in)	PLAT VWF	4.01e-04	4	243	2	DOID:0060573 (is_implicated_in)
Disease	Galloway-Mowat syndrome (is_implicated_in)	NUP107 NUP133	6.64e-04	5	243	2	DOID:0080694 (is_implicated_in)
Disease	Short rib-polydactyly syndrome, Verma-Naumoff type	DYNC2I2 DYNC2I1	6.64e-04	5	243	2	C0432197
Disease	Renal Cell Carcinoma	TET2 CSMD3 MET LMAN2L APRT TGM2	6.89e-04	128	243	6	C0007134
Disease	Sarcomatoid Renal Cell Carcinoma	TET2 CSMD3 MET LMAN2L APRT TGM2	6.89e-04	128	243	6	C1266043
Disease	Chromophobe Renal Cell Carcinoma	TET2 CSMD3 MET LMAN2L APRT TGM2	6.89e-04	128	243	6	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	TET2 CSMD3 MET LMAN2L APRT TGM2	6.89e-04	128	243	6	C1266044
Disease	Papillary Renal Cell Carcinoma	TET2 CSMD3 MET LMAN2L APRT TGM2	6.89e-04	128	243	6	C1306837
Disease	Familial thoracic aortic aneurysm and aortic dissection	MYLK PKD1 MED12 SMAD6	9.57e-04	53	243	4	C4707243
Disease	Nephritis, Interstitial	CLCN5 UMOD APRT	9.82e-04	24	243	3	C0027707
Disease	Degenerative polyarthritis	MYH13 SEC23A IDH3A TGM2 LTBP3	1.05e-03	93	243	5	C0029408
Disease	Osteoarthrosis Deformans	MYH13 SEC23A IDH3A TGM2 LTBP3	1.05e-03	93	243	5	C0086743
Disease	Hypertrophic Cardiomyopathy	OBSCN RYR2 CACNB2 GAA	1.26e-03	57	243	4	C0007194
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	TET2 CSMD3 MET LMAN2L APRT TGM2	1.46e-03	148	243	6	C0279702
Disease	HbA1c measurement	TET2 CD55 SLCO3A1 FN3K PTPRH ARHGAP25 TBCD DOK7 LINC00299 PKD2L1 TET1 HACL1 SLC25A47 CDH15	1.53e-03	675	243	14	EFO_0004541
Disease	Retinitis Pigmentosa	IFT172 PCARE IDH3A PRPF4 RPE65	1.72e-03	104	243	5	C0035334
Disease	Familial Dementia	DNMT1 GRN	1.83e-03	8	243	2	C0751071
Disease	diabetic neuropathy (is_marker_for)	PLAT RETN	1.83e-03	8	243	2	DOID:9743 (is_marker_for)
Disease	Ventricular Dysfunction	IGF2R GAA	1.83e-03	8	243	2	C0242973
Disease	total cholesterol measurement, response to escitalopram, response to citalopram	ARHGAP25 SLIT1	1.83e-03	8	243	2	EFO_0004574, EFO_0006329, EFO_0007871
Disease	Galloway Mowat syndrome	NUP107 NUP133	1.83e-03	8	243	2	C0795949
Disease	Senile Paranoid Dementia	DNMT1 GRN	1.83e-03	8	243	2	C0338630
Disease	hepatocellular carcinoma (biomarker_via_orthology)	MET DNMT1 APEX1 APRT SLC7A5	2.04e-03	108	243	5	DOID:684 (biomarker_via_orthology)
Disease	Hepatocellular carcinoma	MET IGF2R	2.34e-03	9	243	2	cv:C2239176
Disease	HEPATOCELLULAR CARCINOMA	MET IGF2R	2.34e-03	9	243	2	114550
Disease	tissue plasminogen activator measurement	NEGR1 PLAT	2.34e-03	9	243	2	EFO_0004791
Disease	Nonorganic psychosis	CYP2B6 ME2 MED12 TET1	2.55e-03	69	243	4	C0349204
Disease	Adenocarcinoma	CYP26A1 CKB MET DNMT1 MSLN	2.78e-03	116	243	5	C0001418
Disease	Carcinoma, Granular Cell	CYP26A1 CKB MET DNMT1 MSLN	2.78e-03	116	243	5	C0205644
Disease	Adenocarcinoma, Tubular	CYP26A1 CKB MET DNMT1 MSLN	2.78e-03	116	243	5	C0205645
Disease	Adenocarcinoma, Oxyphilic	CYP26A1 CKB MET DNMT1 MSLN	2.78e-03	116	243	5	C0205642
Disease	Carcinoma, Cribriform	CYP26A1 CKB MET DNMT1 MSLN	2.78e-03	116	243	5	C0205643
Disease	Adenocarcinoma, Basal Cell	CYP26A1 CKB MET DNMT1 MSLN	2.78e-03	116	243	5	C0205641
Disease	PR interval	MYCBP2 ABCA12 OBSCN DGKB RYR2 CKB HSPG2 SLC6A15 TGM2 SV2C SLC12A7	2.85e-03	495	243	11	EFO_0004462
Disease	nephrogenic diabetes insipidus (implicated_via_orthology)	CLCNKB GRN	2.91e-03	10	243	2	DOID:12387 (implicated_via_orthology)
Disease	Congenital myasthenic syndrome	DOK7 SLC25A1	2.91e-03	10	243	2	cv:C0751882
Disease	Chronic Kidney Diseases	APRT RETN	2.91e-03	10	243	2	C1561643
Disease	maturity-onset diabetes of the young (implicated_via_orthology)	HK3 TGM2	2.91e-03	10	243	2	DOID:0050524 (implicated_via_orthology)
Disease	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)	RYR2 ANK2	2.91e-03	10	243	2	C1631597
Disease	pulmonary function measurement, forced expiratory volume	TET2 HDAC4 IL37	3.49e-03	37	243	3	EFO_0003892, EFO_0004314
Disease	nephritis (biomarker_via_orthology)	SMAD6 SMAD7	3.54e-03	11	243	2	DOID:10952 (biomarker_via_orthology)
Disease	hepatocellular carcinoma (is_marker_for)	TET2 HDAC4 MET CYP26B1 IGF2R TET1 SLC7A5 SMAD7	3.65e-03	301	243	8	DOID:684 (is_marker_for)
Disease	stenosing tenosynovitis	WWP2 LTBP3	4.22e-03	12	243	2	EFO_0010822
Disease	Amelogenesis Imperfecta	FAM83H LTBP3	4.22e-03	12	243	2	C0002452
Disease	dilated cardiomyopathy (implicated_via_orthology)	MYH1 MYH4 MYH13 MTCH2	4.35e-03	80	243	4	DOID:12930 (implicated_via_orthology)
Disease	Respiratory Depression	PLAT TBCD	4.96e-03	13	243	2	C0235063
Disease	Respiratory Failure	PLAT TBCD	4.96e-03	13	243	2	C1145670
Disease	Respiratory Insufficiency	PLAT TBCD	4.96e-03	13	243	2	C0035229
Disease	Mental Depression	HDAC4 DGKB ADCY7 MED12 GRIA3 GRN APRT	5.28e-03	254	243	7	C0011570
Disease	Malignant neoplasm of prostate	TET2 MATN4 MET SPON2 MED12 DNMT1 AOX1 STEAP4 APEX1 DHX30 IGF2R TIRAP	5.33e-03	616	243	12	C0376358
Disease	Prostatic Neoplasms	TET2 MATN4 MET SPON2 MED12 DNMT1 AOX1 STEAP4 APEX1 DHX30 IGF2R TIRAP	5.33e-03	616	243	12	C0033578
Disease	coffee consumption measurement, tea consumption measurement	TET2 CYP26A1 SCART1	5.70e-03	44	243	3	EFO_0006781, EFO_0010091
Disease	high grade glioma (implicated_via_orthology)	BCAN SLC7A5 MAPKBP1	5.70e-03	44	243	3	DOID:3070 (implicated_via_orthology)
Disease	ascorbic acid 3-sulfate measurement	SLC23A2 CORO1A	5.76e-03	14	243	2	EFO_0800173
Disease	autosomal dominant polycystic kidney disease (implicated_via_orthology)	PKD1 PKD2L1	5.76e-03	14	243	2	DOID:898 (implicated_via_orthology)
Disease	atrial fibrillation (is_implicated_in)	VWF ANK2	5.76e-03	14	243	2	DOID:0060224 (is_implicated_in)
Disease	central nervous system cancer, glioblastoma multiforme	RHBDF1 SLC16A8	5.76e-03	14	243	2	EFO_0000326, EFO_0000519
Disease	polycystic kidney disease (implicated_via_orthology)	IFT172 PKD1	5.76e-03	14	243	2	DOID:0080322 (implicated_via_orthology)
Disease	pulse pressure measurement	TET2 MFHAS1 PLXNB2 MET DIP2A PSMG2 PKD1 ADAMTS15 NEURL1B MTCH2 DNMT1 CACNB2 ANK2 WWP2 CPNE5 MEGF8 TET1 SLIT1 SLC25A47 LTBP3 HCFC1	5.77e-03	1392	243	21	EFO_0005763
Disease	reticulocyte count	PLXNB2 PTPRH SGPL1 PKD1 SLC23A2 MED12 DNMT1 ATRN VWF LAMA4 LINC00299 DNAAF9 TSPAN32 SV2C GAA EPB42 SMAD7	6.19e-03	1045	243	17	EFO_0007986
Disease	N-acetylmethionine measurement	SLCO3A1 DOCK3	6.61e-03	15	243	2	EFO_0021427
Disease	high grade glioma (biomarker_via_orthology)	MET BCAN	6.61e-03	15	243	2	DOID:3070 (biomarker_via_orthology)
Disease	Myopia	LAMA2 GRIA4	6.61e-03	15	243	2	C0027092
Disease	reticulocyte measurement	GPHN KREMEN1 PLXNB2 PTPRH SGPL1 ARHGAP25 SLC23A2 ARHGAP21 MED12 DNMT1 ATRN VWF LINC00299 SV2C SLC12A7 GAA SMAD7	6.66e-03	1053	243	17	EFO_0010700
Disease	nevus count, cutaneous melanoma	HDAC4 PLXNB2 TFAP2B CDH15	6.86e-03	91	243	4	EFO_0000389, EFO_0004632
Disease	Alcoholic Intoxication, Chronic	GPHN CYP2B6 SLCO3A1 ADCY7 VWF TFAP2B CDH15	7.02e-03	268	243	7	C0001973
Disease	Kidney Failure, Chronic	CYP2B6 APRT RETN	7.26e-03	48	243	3	C0022661
Disease	central nervous system disease (implicated_via_orthology)	GRIA3 GRIA4	7.51e-03	16	243	2	DOID:331 (implicated_via_orthology)
Disease	phospholipids in medium LDL measurement	PCSK9 DOK7 IGF2R	7.69e-03	49	243	3	EFO_0022183
Disease	Hepatic fibrosis	ATRN DNAAF9 CDH15	7.69e-03	49	243	3	HP_0001395
Disease	cholesterol in medium LDL measurement	PCSK9 DOK7 IGF2R	7.69e-03	49	243	3	EFO_0022224

Protein segments in the cluster

Peptide	Gene	Start	Entry
SVRGGLEFGCGLFIS	USH1C	101	Q9Y6N9
FEGGCLAELIGSPRD	LINC00299	11	Q6ZSB3
LEETGICVVPGSGFG	GPT2	471	Q8TD30
LGEELVGLGPGSTCL	ERC2-IT1	71	O76042
GGGVLGSCDLVPVRA	EPB42	356	P16452
CTLLIPEGAGGSFSI	AGK	371	Q53H12
FIPFSLGKRICLGEG	CYP2B6	426	P20813
LCGGDVRGPSGTILS	CSMD3	1066	Q7Z407
GYRLEGTSEIICLGG	CSMD3	1211	Q7Z407
LPKLRTLDVFSGCGG	DNMT1	1136	P26358
FIDGLGTLLVGSCPE	B4GALNT2	501	Q8NHY0
ISIGIPAGECFGLLG	ABCA12	2276	Q86UK0
GTRGIASFQCLPALG	ADGRL1	506	O94910
TAGLVAGTRCPDGQF	GRN	11	P28799
SGRFSLPGATCLQGE	GSDMD	181	P57764
DSGSPLLCEGVFRGV	GZMA	211	P12544
AGEGLARGCIVPGVT	C8orf58	16	Q8NAV2
NGEIETIARFGSGPC	APMAP	126	Q9HDC9
CEASGGGAFLVLPLG	CORO1A	51	P31146
PRTAALGVSFGLVAC	ADCY7	616	P51828
EGYSGVGLLSRQCPL	APEX1	126	P27695
PSRGGALLFCTVGIL	DHX30	526	Q7L2E3
GLRVPGNIVYSSLCG	BCOR	81	Q6W2J9
VPQAGGFGCTLAELR	ATP2B3	21	Q16720
PDSFAAVSLCGGLRG	ADAMTS15	111	Q8TE58
GRLVKEGCEIGFIPS	CACNB2	161	Q08289
FGPSLAQELGLGCVL	APRT	71	P07741
TGEVFCSVPGRLSLL	TFAP2B	226	Q92481
IRELCISYGGVGPAT	AOX1	456	Q06278
SGDSGLIPRICEGLF	KIF16B	116	Q96L93
FTGLTPRLCSGVLGT	MTCH2	71	Q9Y6C9
AIPKAGLSSGFIGCV	HSPG2	3806	P98160
ISCILGTGGKSPRLT	NUP107	76	P57740
SAGEIAVTGAGRLPC	PARP9	176	Q8IXQ6
LILTTGGTGFAPRDV	GPHN	81	Q9NQX3
GYLTSRPGVCLVVSG	HACL1	71	Q9UJ83
SAGLLVVLCGRGPSV	CDC42BPG	1141	Q6DT37
GFVDIVARPACGALA	SLC16A8	296	O95907
VCGSGARPDLVGQEF	LRRC3C	186	A6NJW4
GLCRISASGPESLLG	LEMD3	106	Q9Y2U8
FGGDAPTLRLLCSIT	ANK2	1251	Q01484
LRGCSALTGEGLPEA	ARL11	151	Q969Q4
ITGLCDCLPGFTGAL	MEGF10	641	Q96KG7
RCGGGLPGVKTLFLF	BCAN	321	Q96GW7
VAGINACGRGPFSEI	HCFC1	1866	P51610
VLGAGACGGVPIIFS	NUP133	451	Q8WUM0
ACGGVPIIFSRNSGL	NUP133	456	Q8WUM0
GVQIFFLPTLGGGEC	OR2T12	96	Q8NG77
FLPTLGGGECFLLAA	OR2T12	101	Q8NG77
VLASCGPSLGGARVA	KRT84	526	Q9NSB2
FVGEVTSFRLGPCGA	LDLRAD2	161	Q5SZI1
QPITSGGRFLLDCGI	MYLK	71	Q15746
SLASVFVRLPCGGVG	HDAC4	741	P56524
FVRLPCGGVGVDSDT	HDAC4	746	P56524
LRGSICPEEGISAGT	MATN4	561	O95460
TPGRSGLIRCEGAGV	NEGR1	236	Q7Z3B1
AVTRCGFATRGVAGP	NGRN	16	Q9NPE2
GAELGTLPAGFCELA	MFHAS1	236	Q9Y4C4
AGPAIGAEGILTREC	NRAP	276	Q86VF7
VGGDVLSLAPKFCRS	HOXD1	16	Q9GZZ0
LTCPSNLGTGLRAGV	CKB	281	P12277
VVDGGTPVSGFGFRC	MSS51	76	Q4VC12
PSLGSVRAGVLGCLA	LGR6	681	Q9HBX8
PAVFTGDTLFVAGCG	HAGH	176	Q16775
TVLGFAGAVGLTCLG	LRRC53	296	A6NM62
DCVRVLLEAGASPGG	ASB12	111	Q8WXK4
GFCGILSEPSTRGLK	ATRN	891	O75882
GCPCEGTLRLDTLSG	CYP26B1	336	Q9NR63
TFLCGDAGPLAVGAV	LANCL2	146	Q9NS86
VPGGILFGATISFSC	CD55	176	P08174
GEPIFLAGCSDGSIR	DYNC2I1	921	Q8WVS4
ILGTEGGFPLKCSLA	DYNC2I2	351	Q96EX3
TPLLFNGCRSGEIFG	DCAF4L2	236	Q8NA75
CDISPRSLSGRIVGG	GRIA3	621	P42263
CDISPRSLSGRIVGG	GRIA4	611	P48058
VRGSGDVCGVLALAP	NAT14	101	Q8WUY8
GRCVDLFAPGEDIIG	PCSK9	356	Q8NBP7
ALVGTTSGPVRLCIG	PLXNA2	921	O75051
LVSSTGPGGDRVLFV	PLXNB2	156	O15031
ALGVGGGCFIFIIRS	OR14C36	201	Q8NHC7
FLPTLGGGECFLLAA	OR2T8	101	A6NH00
DTRIAGCFLTGIPGL	OR52B6	26	Q8NGF0
DLCFLLVSGRTGNPV	FAM234B	286	A2RU67
GGCTAVVLLVSPRFL	PPM1N	161	Q8N819
GIAGLIGVTCVFPID	SLC25A22	16	Q9H936
APVCGLLGFGVTGLE	NOTO	116	A8MTQ0
LPLFVGSAVGGGTCR	MEGF8	2286	Q7Z7M0
FILQGSLPLVGCGAA	PHRF1	1501	Q9P1Y6
PESLGGIRACTLTVF	KLHL9	581	Q9P2J3
VECGIGFTIILSGLP	SLC7A5	456	Q01650
GIDIGTGASCIYPLL	METTL16	106	Q86W50
AAGSRGCALFPLLGV	MPZL3	6	Q6UWV2
GTVRLRGLPFGCSKE	HNRNPH3	16	P31942
QPCGGDGRIILFDTL	KREMEN1	196	Q96MU8
DGRPTELGGCTAIVR	LMAN2L	191	Q9H0V9
CTLISRGDLAFGAPG	MED12	616	Q93074
AFRGSPLGCVSTSLI	GOLGA6L2	146	Q8N9W4
RSLGLICDGCPVGYT	LAMA2	826	P24043
GGLACDLPGRFVAES	MSLN	186	Q13421
GVLEGIRICRKGFPS	MYH1	701	P12882
GGLPGFICTGLLDTS	NALF2	336	O75949
LVACPRLVGAGAAAG	TEPSIN	476	Q96N21
RAGVTFDPVCLSGIS	PGGHG	606	Q32M88
GVQIFFLPTLGGGEC	OR2T33	96	Q8NG76
FLPTLGGGECFLLAA	OR2T33	101	Q8NG76
VLRGVLNFGGETCPG	PRSS54	236	Q6PEW0
VLFGGCTSPALLSQG	HK3	331	P52790
LTGFAGGLTAACIPV	SLC2A6	141	Q9UGQ3
ESVRSCLYGAGLLPG	TAMALIN	241	Q7Z6J2
RGLGGSRTPLGEFIC	INSM2	251	Q96T92
CGRPGGLFVAGINLT	PLCXD1	241	Q9NUJ7
PGSRCTNIIAGDFIG	PLCXD1	291	Q9NUJ7
AASTGVRALPCLITG	IFT172	1676	Q9UG01
CGTGLVAAELRAPGF	METTL27	76	Q8N6F8
FCRLLEPVCGELGGT	OBSCN	1811	Q5VST9
SVVGGFSICSSPRLL	OXNAD1	106	Q96HP4
VGCGEALGFVSLTGL	POP1	976	Q99575
GEVAVFASRAGPGVC	PRICKLE1	136	Q96MT3
ISSGVFGFPLGRCVE	PARP14	921	Q460N5
VTGTCRLPVGGFADL	ITCH	831	Q96J02
CAAAPAIGTGRIGGL	PAX1	476	P15863
ICGGLVNGPYALITT	SLC37A2	396	Q8TED4
DLCAGLIGGLGVTPS	IDH3A	261	P50213
GSPILLGVSKGEFCL	IL37	106	Q9NZH6
RGTLLPGEVFAICGS	GPCPD1	11	Q9NPB8
GVVICSFRGSVPQGL	DOCK3	11	Q8IZD9
GVCSFLPGRTLVGLS	GAB4	336	Q2WGN9
LVLVLGCGPRASSGG	COL8A2	16	P25067
CGSGIPEIKTILSGF	CLCN5	236	P51795
VTECAGGGAFLVIPL	CORO2A	51	Q92828
PEGLKCGSLRGLYTT	GLB1L	221	Q6UWU2
PDLLGGNGCLGSVVF	DNAAF9	461	Q5TEA3
VPDFRVLACGGDGTV	DGKB	486	Q9Y6T7
LLGVPLVGADVCGFL	GAA	636	P10253
DTLTGSGFRVVVCPL	LTBP3	101	Q9NS15
PSTIIGVAGAGRLFT	ME2	386	P23368
LTEGRCLFASGSPFG	ME2	436	P23368
GITVSGGRGLACDPR	MAPKBP1	46	O60336
LGLVPTRGSLELCDF	IMP3	86	Q9NV31
CELLSPARGGIGAGL	KCTD5	6	Q9NXV2
VFLRGKGSGCIEPAS	KHDC4	271	Q7Z7F0
GFGEDGRTASPQVCI	KLHDC9	331	Q8NEP7
SFIPFGGGLRSCVGK	CYP26A1	431	O43174
GVFGLCALRDGTLVS	EML2	296	O95834
LGLPARAVSTTFGCR	DIP2A	1301	Q14689
GAVPSGFIFEGGTRC	DOK7	161	Q18PE1
PGAVGGERRSLESCL	FAM83H	776	Q6ZRV2
EVVLCGDPLSGFGLQ	GRIP2	456	Q9C0E4
ITAALLFCLGDSPGG	FBXO30	426	Q8TB52
LFCLGDSPGGRGISD	FBXO30	431	Q8TB52
GAAPIAITCFTRGLD	COCH	26	O43405
FGQGSGPIVLDDVRC	DMBT1	1306	Q9UGM3
ILVGAAACGPASDRF	SLC22A12	156	Q96S37
RSLGPEFGGAVGLCF	SLC12A7	191	Q9Y666
IGGVRAIVCPLGAFG	SLC15A5	166	A6NIM6
VGLCTLFGLTPTLNG	SCAP	331	Q12770
DVGDGFIPVCSLGVA	RYR2	1196	Q92736
GVCLPGAAALLAGGT	CDH15	586	P55291
LEVGCGAGNSVFPIL	METTL8	201	Q9H825
PERITIFGSGAGASC	NLGN2	256	Q8NFZ4
VPFCRVVGLLGSLGL	PKD1L1	946	Q8TDX9
LGGPRLGCLFQTDVG	CCDC103	126	Q8IW40
VPFGFEGILRGAATC	SLC7A3	246	Q8WY07
PETIGRRVAVGLGSC	CD22	681	P20273
FCTLGEIVGSPGSRL	CPNE5	116	Q9HCH3
GYILTCPSNLGTGLR	CKMT1A	311	P12532
GLSVSLGRLGTRCEP	PKD1	4196	P98161
RQLESLASGCGDPGV	PCARE	326	A6NGG8
LGVGYGCPEDSLISR	LAMA4	1221	Q16363
GFVRLRGLPFGCTKE	HNRNPF	111	P52597
NSAPLEGGTRLTICG	MET	571	P08581
PGVGACFGQTRISVG	IGF2R	1561	P11717
SLSSFVFGCGILPEG	SESN2	206	P58004
SLLRCGPGLFEVGSE	RPE65	41	Q16518
ISPKLGGIGFASCVV	SLC6A15	136	Q9H2J7
GQPLGGESICSARAL	SPON2	26	Q9BUD6
FCRLLSGFGIGGAIP	SV2C	246	Q496J9
VSFLFLGCDTGPVAG	SLCO3A1	436	Q9UIG8
LLEAVESRGGVPGGC	SMAD6	191	O43541
GGGRVLECPSIRITS	NFATC4	106	Q14934
CLRALGEPITLFGEG	PRPF4	111	O43172
PTGGKARLTEGCSFR	RPS27L	66	Q71UM5
LGGLDAECGRPLFAT	TMEM178A	96	Q8NBL3
GAIFGCLPISGILFS	OR7E24	221	Q6IFN5
FAACIFGGVPLSGII	OR7G2	201	Q8NG99
AGGAVLSGRGSLCFP	PKDREJ	66	Q9NTG1
TATLRAFGGPGAGCI	FN3K	11	Q9H479
EVGPAGSQFGILACL	RHBDF1	716	Q96CC6
RGLFAGVSLEGSCLI	SH3YL1	156	Q96HL8
GSECLPGGNLFGIII	SLC9B2	106	Q86UD5
SGCASGLVRVFLTSP	SLC25A47	101	Q6Q0C1
GVLEGIRICRKGFPS	MYH4	701	Q9Y623
DDFIACVPGSSGGRL	MYCBP2	2241	O75592
GIPLVGADICGFVAE	SI	626	P14410
ECPVTGGTEGLLFVR	ESRP2	381	Q9H6T0
VGGFDRVLLDAPCSG	NOP2	451	P46087
LLVSGFCPRGIGFKE	OVCA2	146	Q8WZ82
GSRLTIPCKVFLGTG	IL1R2	251	P27930
RSLGPEFGGAVGLCF	SLC12A4	191	Q9UP95
AVGLLECTFPNTGAR	SEC23A	271	Q15436
AEIVRIACSLFNGGP	SGPL1	186	O95470
LVGGEACSPTARIGG	TBC1D9B	1176	Q66K14
GSKEGRPFSGVTACL	TET1	1651	Q8NFU7
RCFLPRLDTGTAGTV	AURKAIP1	81	Q9NWT8
ACGSTLFLGKVGPFV	CLCNKB	156	P51801
TCSLLGLFGFSVGPV	SLC49A3	346	Q6UXD7
ARTVSYNGILGPECG	TGM2	511	P21980
TFGRLCPVSETFGRL	nan	71	Q6ZQT0
ESRGGTRTACLLLPG	SMAD7	116	O15105
SGDRIGCGIEPVSFD	SPRYD3	141	Q8NCJ5
QFVTGTCRLPVGGFA	WWP2	796	O00308
TCRLPVGGFAELIGS	WWP2	801	O00308
PGERFLCGGILISSC	PLAT	336	P00750
GACPTRDFVVGALIL	ZCCHC3	176	Q9NUD5
EGFRLSPGLGCTDVD	UMOD	96	P07911
ILPGTLCAEGTRGRS	VWF	16	P04275
GGCVAFILDNTIPGT	SLC23A2	561	Q9UGH3
EAVAIGPRGCSGSLR	TSPAN32	266	Q96QS1
GAGLLAACFIAIVPG	STT3B	196	Q8TCJ2
GTPCGVFGQRLDETV	ARHGAP25	151	P42331
GLAAPGALAFGITSC	NEURL1B	331	A8MQ27
GALAFGITSCDPGVL	NEURL1B	336	A8MQ27
VPSLIAGLFVGCLAG	TMEM14A	26	Q9Y6G1
DCGLAPAALTRIVGG	TMPRSS9	816	Q7Z410
AGGLAGGIEICITFP	SLC25A1	31	P53007
GVLEGIRICRKGFPS	MYH13	701	Q9UKX3
GCREILTTAGPFTVL	STAB1	386	Q9NY15
TVCIFGTGDFGRSLG	STEAP4	21	Q687X5
CGAVVSTPEGARFGR	SCART1	271	Q4G0T1
LRELSFSGIPCEGGL	TBC1D13	26	Q9NVG8
VFIVDSGGTCAGLLP	UNQ9370/PRO34162	161	Q6UXP9
CLGGRLSIPGTGVSL	UNC5B	551	Q8IZJ1
LVCGDRRGSVLLFPS	WDR6	506	Q9NNW5
PLSGEGGSFVDACRL	PSME4	1451	Q14997
GISCLVDAFLGISRP	RALGAPB	341	Q86X10
CVLRLVVEFPATGGA	PKD2L1	316	Q9P0L9
TGRRPSGLCGAALLV	BRF1	221	Q92994
GLEGRGIPEGACTAL	PLCH1	1646	Q4KWH8
CFLQLRDATPGGAIV	TIRAP	116	P58753
CVAGLFFIPVAGLTG	ZDHHC5	191	Q9C0B5
TSLPALGGVCGREGA	ZNF252P-AS1	11	Q0IIN9
LGGPLSLVEGTGLAC	ZNF316	636	A6NFI3
LTGSASCGVPGILRK	VXN	171	Q8TAG6
IPEGAVCRGELLGSG	TNK1	111	Q13470
LFGVVPGAAETGDVC	ZKSCAN7	301	Q9P0L1
CVAGLFFIPVIGLTG	ZDHHC8	191	Q9ULC8
EFCIRIPGGGITKTL	PSMG2	176	Q969U7
PTGCGFLLAATCLRG	SLC35E4	186	Q6ICL7
TRCGFSLALGALPGF	TBCD	771	Q9BTW9
FCLLGAGPVDSGVTQ	TRBV9	11	A0A0B4J1U6
SVCRDFGVPGGTLRG	TIGD5	76	Q53EQ6
LDGPGGNCVAVLTLF	GTF3C1	1561	Q12789
IGLFTQCSGPASLRG	SLIT1	236	O75093
RTGLLVGSCAGLFGV	TMEM177	16	Q53S58
AEVGPAGSQFGLLAC	RHBDF2	716	Q6PJF5
SRGDLATCPRGFAVT	RETN	56	Q9HD89
GPAFEAGLCTGDRII	ARHGAP21	111	Q5T5U3
GLKEGRPFSGVTACL	TET2	1361	Q6N021
RVTVDGLGPGSLYTC	PTPRH	261	Q9HD43
SCGEAVSVLGLGPAR	PTPRH	711	Q9HD43
PTGGKARLTEGCSFR	RPS27	66	P42677
LLTDARCLPGTEGGG	TYSND1	251	Q2T9J0
RCLPGTEGGGVFTAR	TYSND1	256	Q2T9J0
GGFDVLVADPVTICG	UGT2A2	151	P0DTE5
SIRVTGPGGVFCIGS	LIN28A	106	Q9H9Z2